CVS Health Corporation
(NYSE:CVS)

CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and ...

Website: http://www.cvshealth.com

Founded: 1963

Full Time Employees: 300,000 (Jun 2022)

Sector: Healthcare

Industry: Healthcare Plans

Pharmaceuticals

Share this website to your friends

• Market Cap:

• Exchange:

• Shs Outstanding:

• Employees:

• Beta:

• Return on Equity (ROE) ttm:

• Return on Assets (ROA) ttm:

• EPS ttm:

• Book value per Share:

• Cash per Share:

• Current ast per Share:

• P/E ttm:

• P/E forward:

• P/E ttm high:

• P/E ttm low:

• P/S ttm:

• P/B ttm:

• P/FCF ttm:

• PEG ratio:

• Cash Ratio ttm:

• Quick Ratio ttm:

• Current Ratio ttm:

• Gross Mgn ttm:

• EBITDA Mgn ttm:

• Operating Mgn ttm:

• Net Income Mgn ttm:

• Trailing Div yield:

• Forward Div yield:

• Payout Ratio ttm:

• Ex-Dividend date:

• Target Price High:

• Target Price Low:

• Target Price Mean:

• Number of Analysts:

• Debt Ratio ttm:

• Debt to Equity ttm:

• Total Net Debt:

At a glance:

Bull Thesis:

Bear Thesis:

Main Competitors:

Moat:

Income Statements:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-09-30	2009-06-30	2009-03-31	2008-09-27	2008-06-28	2008-03-29	2007-12-29	2007-09-29	2007-06-30	2007-03-31	2006-12-30

revenues:
products	62,226,000,000	67,042,000,000	64,590,000,000	60,607,000,000	57,669,000,000	61,911,000,000	59,674,000,000	56,212,000,000	53,724,000,000	65,154,000,000	61,298,000,000	60,539,000,000	58,147,000,000	59,657,000,000	57,643,000,000	56,794,000,000	52,522,000,000	53,973,000,000	51,853,000,000	50,525,000,000	47,387,000,000	49,592,000,000	47,738,000,000	46,355,000,000	47,003,000,000	49,213,000,000	47,149,000,000	45,531,000,000	43,343,000,000
premiums	33,791,000,000	34,017,000,000	33,719,000,000	34,195,000,000	32,820,000,000	30,913,000,000	30,925,000,000	30,667,000,000	30,391,000,000	25,075,000,000	24,657,000,000	25,108,000,000	24,352,000,000	21,436,000,000	21,003,000,000	21,260,000,000	21,631,000,000	19,205,000,000	18,984,000,000	18,983,000,000	18,960,000,000	17,615,000,000	17,182,000,000	16,927,000,000	17,640,000,000	15,510,000,000	15,539,000,000	15,791,000,000	16,282,000,000
services	3,835,000,000	4,040,000,000	3,930,000,000	3,626,000,000	3,579,000,000	4,131,000,000	4,279,000,000	3,961,000,000	3,868,000,000	3,316,000,000	3,532,000,000	3,000,000,000	2,445,000,000	2,430,000,000	2,312,000,000	2,436,000,000	2,505,000,000	3,059,000,000	2,711,000,000	2,819,000,000	2,453,000,000	2,099,000,000	1,932,000,000	1,875,000,000	1,950,000,000	1,960,000,000	1,859,000,000	1,816,000,000	1,772,000,000
net investment income	574,000,000	594,000,000	632,000,000	487,000,000	520,000,000	755,000,000	550,000,000	394,000,000	454,000,000	268,000,000	277,000,000	274,000,000	334,000,000	323,000,000	201,000,000	146,000,000	168,000,000	367,000,000	246,000,000	289,000,000	297,000,000	248,000,000	204,000,000	184,000,000	162,000,000	206,000,000	263,000,000	293,000,000	249,000,000
total revenues	100,426,000,000	105,693,000,000	102,871,000,000	98,915,000,000	94,588,000,000	97,710,000,000	95,428,000,000	91,234,000,000	88,437,000,000	93,813,000,000	89,764,000,000	88,921,000,000	85,278,000,000	83,846,000,000	81,159,000,000	80,636,000,000	76,826,000,000	76,604,000,000	73,794,000,000	72,616,000,000	69,097,000,000	69,554,000,000	67,056,000,000	65,341,000,000	66,755,000,000	66,889,000,000	64,810,000,000	63,431,000,000	61,646,000,000
yoy	6.17%	8.17%	7.80%	8.42%	6.96%	4.15%	6.31%	2.60%	3.70%	11.89%	10.60%	10.27%	11.00%	9.45%	9.98%	11.04%	11.19%	10.14%	10.05%	11.13%	3.51%	3.98%	3.47%	3.01%	8.29%
qoq	-4.98%	2.74%	4.00%	4.57%	-3.20%	2.39%	4.60%	3.16%	-5.73%	4.51%	0.95%	4.27%	1.71%	3.31%	0.65%	4.96%	0.29%	3.81%	1.62%	5.09%	-0.66%	3.73%	2.62%	-2.12%	-0.20%	3.21%	2.17%	2.90%
operating costs:
cost of products sold	55,444,000,000	59,060,000,000	57,045,000,000	54,005,000,000	51,057,000,000	55,268,000,000	52,948,000,000	49,998,000,000	48,073,000,000	57,419,000,000	54,688,000,000	53,536,000,000	51,455,000,000	51,728,000,000	50,365,000,000	49,290,000,000	45,509,000,000	46,378,000,000	45,011,000,000	43,520,000,000	40,894,000,000	42,452,000,000	40,940,000,000	40,242,000,000	40,347,000,000	42,065,000,000	40,437,000,000	38,970,000,000	37,247,000,000
health care costs	29,358,000,000	33,066,000,000	32,020,000,000	31,317,000,000	29,135,000,000	29,543,000,000	29,922,000,000	27,853,000,000	27,803,000,000	22,518,000,000	21,499,000,000	21,782,000,000
operating expenses	10,944,000,000	11,455,000,000	11,288,000,000	11,212,000,000	11,022,000,000	10,421,000,000	10,557,000,000	10,338,000,000	10,290,000,000	10,503,000,000	9,876,000,000	9,873,000,000	9,580,000,000	10,084,000,000	9,606,000,000	9,171,000,000	9,876,000,000	10,065,000,000	9,210,000,000	8,869,000,000	8,922,000,000	9,433,000,000	8,471,000,000	8,668,000,000	8,563,000,000	8,654,000,000	8,595,000,000	8,042,000,000	8,250,000,000			4,913,000,000	4,796,000,000	4,627,000,000	4,818,000,000	4,787,000,000	4,611,000,000	4,675,000,000	4,665,000,000	4,568,000,000	4,572,000,000	4,330,000,000	4,140,000,000	4,032,000,000	4,312,000,000	4,222,000,000	4,116,000,000	3,918,000,000	4,122,000,000	3,874,000,000	3,868,000,000	3,883,000,000	3,994,000,000	3,833,000,000	3,741,000,000	3,709,000,000	3,598,000,000	3,594,000,000	3,605,000,000	3,440,000,000	3,696,000,000	3,540,000,000	3,519,000,000	3,336,000,000	3,445,800,000	3,452,400,000		2,934,400,000	2,895,100,000		2,084,875,000	2,924,100,000	2,848,700,000
total operating costs	95,746,000,000	103,581,000,000	106,078,000,000	96,534,000,000	91,214,000,000	95,342,000,000	94,596,000,000	88,189,000,000	86,166,000,000	90,440,000,000	86,074,000,000	85,687,000,000	81,832,000,000	80,228,000,000	85,090,000,000	76,067,000,000	73,336,000,000	74,375,000,000	70,733,000,000	68,290,000,000	65,520,000,000	67,030,000,000	63,807,000,000	60,661,000,000	63,297,000,000	63,852,000,000	61,882,000,000	60,099,000,000	58,956,000,000
operating income	4,680,000,000	2,112,000,000	-3,207,000,000	2,381,000,000	3,374,000,000	2,368,000,000	832,000,000	3,045,000,000	2,271,000,000	3,373,000,000	3,690,000,000	3,234,000,000	3,446,000,000	3,618,000,000	-3,931,000,000	4,569,000,000	3,490,000,000	2,229,000,000	3,061,000,000	4,326,000,000	3,577,000,000	2,524,000,000	3,249,000,000	4,680,000,000	3,458,000,000	3,037,000,000	2,928,000,000	3,332,000,000	2,690,000,000
yoy	38.71%	-10.81%	-485.46%	-21.81%	48.57%	-29.80%	-77.45%	-5.84%	-34.10%	-6.77%	-193.87%	-29.22%	-1.26%	62.31%	-228.42%	5.62%	-2.43%	-11.69%	-5.79%	-7.56%	3.44%	-16.89%	10.96%	40.46%	28.55%
qoq	121.59%	-165.86%	-234.69%	-29.43%	42.48%	184.62%	-72.68%	34.08%	-32.67%	-8.59%	14.10%	-6.15%	-4.75%	-192.04%	-186.04%	30.92%	56.57%	-27.18%	-29.24%	20.94%	41.72%	-22.31%	-30.58%	35.34%	13.86%	3.72%	-12.12%	23.87%
operating margin %	4.66%	2.00%	-3.12%	2.41%	3.57%	2.42%	0.87%	3.34%	2.57%	3.60%	4.11%	3.64%	4.04%	4.32%	-4.84%	5.67%	4.54%	2.91%	4.15%	5.96%	5.18%	3.63%	4.85%	7.16%	5.18%	4.54%	4.52%	5.25%	4.36%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%
interest expense	-774,000,000	-787,000,000	-784,000,000	763,000,000	785,000,000	758,000,000	752,000,000	732,000,000	716,000,000	690,000,000	693,000,000	686,000,000	589,000,000	552,000,000	566,000,000	583,000,000	586,000,000	608,000,000	602,000,000	636,000,000	657,000,000	678,000,000	731,000,000	765,000,000	733,000,000	734,000,000	747,000,000	772,000,000	782,000,000	453	475,000,000	473,000,000	297,000,000	245,000,000	247,000,000	252,000,000	242,000,000	253,000,000	280,000,000	283,000,000	276,000,000	261,000,000	166,000,000	134,000,000	131,000,000	153,000,000	158,000,000	158,000,000	135,000,000	122,000,000	126,000,000	126,000,000	160,000,000	134,000,000	132,000,000	132,000,000	147,000,000	155,000,000	148,000,000	134,000,000	137,000,000	137,000,000	135,000,000	128,000,000	122,800,000	127,900,000	142,100,000	112,700,000	114,700,000	130,900,000	137,300,000	127,500,000	105,900,000	63,900,000
other income	32,000,000	29,000,000	26,000,000	-29,000,000	-28,000,000	-25,000,000	-25,000,000	-24,000,000	-25,000,000	-22,000,000	-22,000,000	-22,000,000	-22,000,000	-43,000,000	-41,000,000	-43,000,000	-42,000,000	-38,000,000	-49,000,000	-45,000,000	-50,000,000	-53,000,000	-54,000,000	-45,000,000	-54,000,000
income before income tax provision	3,938,000,000	1,354,000,000	-3,482,000,000	1,647,000,000	2,617,000,000	2,126,000,000	105,000,000	2,337,000,000	1,580,000,000	2,705,000,000	3,019,000,000	2,570,000,000	2,879,000,000	3,109,000,000	-4,456,000,000	4,029,000,000	2,946,000,000	1,570,000,000	2,145,000,000	3,735,000,000	2,970,000,000	1,225,000,000	1,806,000,000	3,960,000,000	2,779,000,000	2,334,000,000	2,133,000,000	2,591,000,000	1,939,000,000	1,899	-2,065,000,000	1,470,000,000	2,809,000,000	2,062,000,000	1,863,000,000	1,534,000,000	1,471,000,000	2,463,000,000	1,528,000,000	1,893,000,000	1,540,750,000	2,070,000,000	2,096,000,000	1,998,000,000	1,372,000,000	1,572,000,000	2,050,000,000	1,866,000,000	1,363,500,000	2,039,000,000	1,842,000,000	1,573,000,000	1,132,000,000	1,680,000,000	1,576,000,000	1,272,000,000	984,000,000	1,429,000,000	1,342,000,000	1,177,000,000	998,750,000	1,347,000,000	1,366,000,000	1,282,000,000
income tax provision	981,000,000	-1,569,000,000	508,000,000	634,000,000	835,000,000	503,000,000	34,000,000	569,000,000	456,000,000	658,000,000	754,000,000	656,000,000	737,000,000	809,000,000	-1,047,000,000	1,068,000,000	633,000,000	274,000,000	558,000,000	944,000,000	746,000,000	241,000,000	587,000,000	974,000,000	767,000,000	590,000,000	604,000,000	660,000,000	512,000,000	509	497,000,000	472,000,000	-478,000,000	777,000,000	766,000,000	572,000,000	1,046,000,000	921,000,000	604,000,000	746,000,000	953,000,000	833,000,000	824,000,000	777,000,000	868,000,000	624,000,000	804,000,000	737,000,000	812,000,000	779,000,000	720,000,000	617,000,000	666,000,000	669,000,000	610,000,000	496,000,000	711,000,000	562,000,000	526,000,000	464,000,000	608,000,000	528,000,000	544,000,000	510,000,000	420,000,000	582,800,000	491,600,000	534,700,000	539,900,000	490,700,000	523,600,000	454,100,000	480,300,000	263,700,000
net income	2,957,000,000	2,923,000,000	-3,990,000,000	1,013,000,000	1,782,000,000	1,623,000,000	71,000,000	1,768,000,000	1,124,000,000	2,047,000,000	2,265,000,000	1,914,000,000	2,142,000,000	2,300,000,000	-3,409,000,000	2,961,000,000	2,313,000,000	1,296,000,000	1,587,000,000	2,791,000,000	2,224,000,000	975,000,000	1,219,000,000	2,986,000,000	2,012,000,000	1,744,000,000	1,529,000,000	1,931,000,000	1,427,000,000	1,390	-2,563,000,000	998,000,000	3,287,000,000	1,285,000,000	1,098,000,000	953,000,000	1,707,000,000	1,541,000,000	924,000,000	1,147,000,000	1,499,000,000	1,247,000,000	1,272,000,000	1,221,000,000	1,321,000,000	948,000,000	1,246,000,000	1,129,000,000	1,261,000,000	1,254,000,000	1,121,000,000	956,000,000	1,129,000,000	1,006,000,000	965,000,000	775,000,000	1,063,000,000	867,000,000	815,000,000	712,000,000	1,025,000,000	808,000,000	821,000,000	770,000,000	1,021,300,000
yoy	65.94%	80.10%	-5719.72%	-42.70%	58.54%	-20.71%	-96.87%	-7.63%	-47.53%	-11.00%	-166.44%	-35.36%	-7.39%	77.47%	-314.81%	6.09%	4.00%	32.92%	30.19%	-6.53%	10.54%	-44.09%	-20.27%	54.63%	41.00%	125467525.90%	-159.66%	93.49%	-56.59%	-100.00%	-333.42%	4.72%	92.56%	-16.61%	18.83%	-16.91%	13.88%	23.58%	-27.36%	-6.06%	13.47%	31.54%	2.09%	8.15%	4.76%	-24.40%	11.15%	18.10%	11.69%	24.65%	16.17%	23.35%	6.21%	16.03%	18.40%	8.85%	3.71%	7.30%	-0.73%	-7.53%	0.36%
qoq	1.16%	-173.26%	-493.88%	-43.15%	9.80%	2185.92%	-95.98%	57.30%	-45.09%	-9.62%	18.34%	-10.64%	-6.87%	-167.47%	-215.13%	28.02%	78.47%	-18.34%	-43.14%	25.49%	128.10%	-20.02%	-59.18%	48.41%	15.37%	14.06%	-20.82%	35.32%	102661770.50%	-100.00%	-356.81%	-69.64%	155.80%	17.03%	15.22%	-44.17%	10.77%	66.77%	-19.44%	-23.48%	20.21%	-1.97%	4.18%	-7.57%	39.35%	-23.92%	10.36%	-10.47%	0.56%	11.86%	17.26%	-15.32%	12.23%	4.25%	24.52%	-27.09%	22.61%	6.38%	14.47%	-30.54%	26.86%	-1.58%	6.62%	-24.61%
net income margin %	2.94%	2.77%	-3.88%	1.02%	1.88%	1.66%	0.07%	1.94%	1.27%	2.18%	2.52%	2.15%	2.51%	2.74%	-4.20%	3.67%	3.01%	1.69%	2.15%	3.84%	3.22%	1.40%	1.82%	4.57%	3.01%	2.61%	2.36%	3.04%	2.31%	Infinity%	-Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%	NaN%
net income attributable to noncontrolling interests	-14,000,000				-3,000,000				-11,000,000	-5,750,000	-4,000,000	-13,000,000	-6,000,000			-10,000,000	-1,000,000			-8,000,000	-1,000,000				-5,000,000				-6,000,000
net income attributable to cvs health	2,943,000,000	2,943,000,000	-3,975,000,000	1,021,000,000	1,779,000,000	1,644,000,000	87,000,000	1,770,000,000	1,113,000,000	2,046,000,000	2,261,000,000	1,901,000,000	2,136,000,000	2,302,000,000	-3,416,000,000	2,951,000,000	2,312,000,000	1,306,000,000	1,598,000,000	2,783,000,000	2,223,000,000	973,000,000	1,224,000,000	2,975,000,000	2,007,000,000	1,747,000,000	1,530,000,000	1,936,000,000	1,421,000,000	1,390	-2,563,000,000	998,000,000	3,287,000,000	1,285,000,000	1,098,000,000	952,000,000	1,707,000,000	1,540,000,000	924,000,000	1,146,000,000	1,498,000,000	1,246,000,000
net income per share
basic	2.31	2.33	-3.13	0.81	1.41	1.31	0.07	1.41	0.88	1.59	1.76	1.48	1.66	0.353	-2.6	2.25	1.76	1.253	1.21	2.11	1.69	1.185	0.93	2.27	1.54				1.09										0.86	1.04			1.13	1.08				0.96
diluted	2.3	2.32	-3.13	0.8	1.41	1.31	0.07	1.41	0.88	1.59	1.75	1.48	1.65	0.35	-2.6	2.23	1.74	1.245	1.2	2.1	1.68	1.18	0.93	2.26	1.53				1.09										0.86	1.04			1.12	1.07				0.95
weighted-average shares outstanding:
basic	1,273	1,267	1,269	1,266	1,261	1,259	1,259	1,256	1,260	1,285	1,287	1,283	1,283		1,315	1,313	1,312		1,321	1,319	1,313		1,310	1,309	1,306				1,298										1,070	1,092			1,124	1,128				1,180
diluted	1,279	1,271	1,269	1,270	1,264	1,262	1,259	1,259	1,267	1,290	1,290	1,287	1,291		1,315	1,321	1,328		1,329	1,327	1,322		1,315	1,314	1,312				1,302										1,075	1,099			1,132	1,136				1,190
goodwill impairment			5,725,000,000																431,000,000
restructuring charges						10,000,000	1,169,000,000				11,000,000
gain on deconsolidation of subsidiary			483,000,000
net loss attributable to noncontrolling interests		20,000,000	15,000,000	8,000,000		21,000,000	16,000,000	2,000,000						2,000,000	-7,000,000			10,000,000	11,000,000			-2,000,000	5,000,000	-11,000,000			1,000,000	5,000,000
loss on assets held for sale													349,000,000	12,000,000	2,480,000,000
dividends declared per share						0.499	0.665	0.665	0.665	0.605	0.605	0.605	0.605	0.55	0.55	0.55	0.55	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.319	0.425	0.425	0.425	0.263	0.35	0.35	0.35	0.206	0.275	0.275	0.275
restructuring charge												496,000,000
opioid litigation charges														99,000,000	5,220,000,000
opioid litigation charge
benefit costs													20,448,000,000	18,305,000,000	17,419,000,000	17,606,000,000	17,951,000,000	16,574,000,000	16,081,000,000	15,901,000,000	15,704,000,000	15,145,000,000	14,396,000,000	11,751,000,000	14,387,000,000	13,133,000,000	12,850,000,000	13,087,000,000	13,459,000,000
loss on early extinguishment of debt																		89,000,000	363,000,000			674,000,000	766,000,000				79,000,000											101,000,000	542,000,000							521,000,000
other expense																										-31,000,000	-31,000,000	-31,000,000	-31,000,000	1	3,000,000	3,000,000	2,000,000	192,000,000	7,000,000	7,000,000
income from continuing operations																										1,744,000,000	1,529,000,000	1,931,000,000		1,390	-2,562,000,000	998,000,000	3,287,000,000	1,285,000,000	1,097,000,000	962,000,000	1,707,000,000	1,542,000,000			1,500,000,000	1,237,000,000			1,322,000,000	948,000,000	1,246,000,000		1,262,000,000	1,260,000,000	1,122,000,000	956,000,000	1,129,000,000	1,011,000,000	966,000,000	776,000,000	1,099,000,000	867,000,000	816,000,000	713,000,000	1,026,000,000	819,000,000	822,000,000	772,000,000	1,023,100,000
loss from discontinued operations, net of tax																																																	-1,750,000	-6,000,000	-1,000,000										-3,500,000	-11,000,000	-1,000,000	-2,000,000
basic earnings per share:
income from continuing operations attributable to cvs health																										1.34	1.17	1.49		1.36	-2.52	0.98	3.22	1.26	1.07	0.93	4,929,996.66	1.44			4,649,996.69	1.1
loss from discontinued operations attributable to cvs health																																	-0.003			-0.01
weighted-average basic shares outstanding														1,312				1,319				1,309				1,301	1,302											1,068				1,114				1,157	1,165
diluted earnings per share:
weighted-average diluted shares outstanding														1,323				1,329				1,314				1,305	1,305											1,073				1,121				1,164	1,174
weighted-average shares outstanding																												1,301		1,020	1,018	1,016	1,020	1,016	1,019	1,030
net revenues																														47,269	46,708,000,000	45,693,000,000	48,385,000,000	46,181,000,000	45,685,000,000	44,514,000,000	45,971,000,000	44,615,000,000	43,725,000,000	43,215,000,000	41,146,000,000	38,644,000,000	37,169,000,000	36,332,000,000	37,055,000,000	35,021,000,000	34,602,000,000	32,689,000,000	32,782,000,000	31,968,000,000	31,248,000,000	30,763,000,000	31,394,000,000	30,227,000,000	30,714,000,000	30,798,000,000	28,317,000,000	26,674,000,000	26,629,000,000	25,880,000,000	24,772,000,000	23,875,000,000	24,007,000,000	23,760,000,000	24,641,900,000	24,871,100,000	23,393,900,000	20,863,400,000	21,140,300,000	21,326,000,000	21,942,400,000	20,495,200,000	20,703,300,000	13,184,600,000
cost of revenues																														39,941	39,507,000,000	38,834,000,000	40,481,000,000	39,055,000,000	38,750,000,000	37,934,000,000	27,576,000,000	37,123,000,000	36,710,000,000	36,471,000,000	23,229,250,000	31,983,000,000	30,767,000,000	30,168,000,000	20,894,500,000	28,553,000,000	28,278,000,000	26,747,000,000	19,131,750,000	25,933,000,000	25,412,000,000	25,181,000,000	18,882,500,000	24,580,000,000	25,265,000,000	25,685,000,000	15,944,250,000	21,496,000,000	21,534,000,000	21,129,000,000	14,212,750,000	18,851,000,000	18,987,000,000	19,014,000,000	19,630,200,000	19,818,900,000	18,645,900,000	16,462,800,000	16,767,100,000	17,033,000,000	17,491,600,000	16,300,000,000	16,544,800,000	9,835,400,000
gross profit																														7,328	7,201,000,000	6,859,000,000	7,904,000,000	7,126,000,000	6,935,000,000	6,580,000,000	7,606,000,000	7,492,000,000	7,015,000,000	6,744,000,000	7,301,000,000	6,661,000,000	6,402,000,000	6,164,000,000	6,633,000,000	6,468,000,000	6,324,000,000	5,942,000,000	6,331,000,000	6,035,000,000	5,836,000,000	5,582,000,000	6,297,000,000	5,647,000,000	5,449,000,000	5,113,000,000	5,555,000,000	5,178,000,000	5,095,000,000	4,751,000,000	5,467,000,000	5,024,000,000	5,020,000,000	4,746,000,000	5,011,700,000	5,052,200,000	4,748,000,000	4,400,600,000	4,373,200,000	4,293,000,000	4,450,800,000	4,195,200,000	4,158,500,000	3,349,200,000
yoy																														-100.00%	3.84%	4.24%	3.92%	-4.89%	-1.14%	-2.43%	4.18%	12.48%	9.58%	9.41%	10.07%	2.98%	1.23%	3.74%	4.77%	7.17%	8.36%	6.45%	0.54%	6.87%	7.10%	9.17%	13.36%	9.06%	6.95%	7.62%	1.61%	3.07%	1.49%	0.11%	9.08%	-0.56%	5.73%	7.85%	14.60%	17.68%	6.68%	4.90%	5.16%	28.18%
qoq																														-100.00%	4.99%	-13.22%	10.92%	2.75%	5.40%	-13.49%	1.52%	6.80%	4.02%	-7.63%	9.61%	4.05%	3.86%	-7.07%	2.55%	2.28%	6.43%	-6.14%	4.90%	3.41%	4.55%	-11.35%	11.51%	3.63%	6.57%	-7.96%	7.28%	1.63%	7.24%	-13.10%	8.82%	0.08%	5.77%	-5.30%	-0.80%	6.41%	7.89%	0.63%	1.87%	-3.55%	6.09%	0.88%	24.16%
gross margin %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%	Infinity%
operating expenses:
goodwill impairments																															3,921,000,000
other operating expenses																														4,975	4,867,000,000
operating profit																														2,353	-1,587,000,000	1,946,000,000	3,108,000,000	2,499,000,000	2,117,000,000	1,793,000,000	2,995,000,000	2,817,000,000	2,350,000,000	2,176,000,000	2,729,000,000	2,331,000,000	2,262,000,000	2,132,000,000	2,321,000,000	2,246,000,000	2,208,000,000	2,024,000,000	2,209,000,000	2,161,000,000	1,968,000,000	1,699,000,000	2,303,000,000	1,814,000,000	1,708,000,000	1,404,000,000	1,957,000,000	1,584,000,000	1,490,000,000	1,311,000,000	1,771,000,000	1,484,000,000	1,501,000,000	1,410,000,000	1,565,900,000	1,599,800,000	1,377,200,000	1,466,200,000	1,478,100,000	1,370,100,000	1,475,900,000	1,271,100,000	1,309,800,000	736,500,000
income from discontinued operations, net of tax																																			1,000,000		-250,000	-1,000,000			2,500,000	10,000,000															1,250,000
net income attributable to noncontrolling interest																																					-500,000	-1,000,000		-1,000,000	-250,000	-1,000,000
income from discontinued operations attributable to cvs health																																									9,999.99	0.01
loss from discontinued operations																																																													-2,500	-10,000			-10,000		-3,000	-60,000	-30,000
weighted-averages shares outstanding:
basic	1,273	1,267	1,269	1,266	1,261	1,259	1,259	1,256	1,260	1,285	1,287	1,283	1,283		1,315	1,313	1,312		1,321	1,319	1,313		1,310	1,309	1,306				1,298										1,070	1,092			1,124	1,128				1,180
diluted	1,279	1,271	1,269	1,270	1,264	1,262	1,259	1,259	1,267	1,290	1,290	1,287	1,291		1,315	1,321	1,328		1,329	1,327	1,322		1,315	1,314	1,312				1,302										1,075	1,099			1,132	1,136				1,190
net loss attributable to noncontrolling interest																																																							1,000,000	1,000,000	1,000,000	1,000,000	1,000,000	1,000,000	1,000,000	1,000,000		1,000,000
net income attributable to cvs caremark																																																	1,261,000,000	1,254,000,000	1,121,000,000	956,000,000	1,129,000,000	1,006,000,000	966,000,000	776,000,000	1,064,000,000	868,000,000	816,000,000	713,000,000	1,026,000,000	809,000,000	821,000,000	771,000,000
basic earnings per common share:
income from continuing operations attributable to cvs caremark																																																	1,060,000	1,040,000	910,000	780,000	910,000	800,000	760,000	600,000	840,000	650,000	600,000	520,000	760,000	600,000	610,000	560,000
loss from discontinued operations attributable to cvs caremark																																																		-10,000
weighted-average basic common shares outstanding																																																		1,218,000,000	1,227,000,000	1,232,000,000		1,265,000,000	1,278,000,000	1,299,000,000		1,332,000,000	1,355,000,000	1,362,000,000		1,360,000,000	1,359,000,000	1,386,000,000	1,429,400,000	1,456,900,000	1,450,000,000	1,435,500,000	1,431,800,000	1,429,800,000		1,473,700,000	1,492,400,000	906,100,000
diluted earnings per common share:
weighted-average diluted common shares outstanding																																																		1,226,000,000	1,236,000,000	1,241,000,000		1,274,000,000	1,287,000,000	1,309,000,000		1,340,000,000	1,364,000,000	1,371,000,000		1,368,000,000	1,369,000,000	1,396,000,000	1,444,900,000	1,471,800,000	1,468,900,000	1,469,700,000	1,468,700,000	1,467,700,000		1,521,200,000	1,542,500,000	939,800,000
dividends declared per common share																																																	168,750	225,000	225,000	225,000	121,875	162,500	162,500	162,500	93,750	125,000	125,000	125,000	65,625	87,500	87,500	87,500	76,250	76,250	76,250	69,000	60,000	60,000	60,000	60,000	60,000	48,750
income from discontinued operations attributable to cvs caremark																																																					-2,500				2,500
income (loss) from discontinued operations, net of tax
income from continuing operations before income tax provision																																																																	1,443,100,000
loss from discontinued operations, net of tax benefit																																																																	-1,800,000	-2,600,000
preference dividends, net of income tax benefit																																																																				3,500,000	3,600,000	3,500,000	3,800,000	3,400,000	3,500,000	3,500,000
net income available to common shareholders																																																																	1,021,300,000
earnings from continuing operations before income tax provision																																																																		1,471,900,000	1,235,100,000	1,353,500,000	1,363,400,000
earnings from continuing operations																																																																		889,100,000	743,500,000	818,800,000	823,500,000
net earnings																																																																		886,500,000	738,400,000	736,000,000	774,800,000	748,500,000	815,000,000	689,500,000	723,600,000	408,900,000
net earnings available to common shareholders																																																																		886,500,000	738,400,000	732,500,000	771,200,000	745,000,000	811,200,000	686,100,000	720,100,000	405,400,000
total operating expenses																																																																			3,370,800,000			2,922,900,000				2,612,700,000
loss from discontinued operations, net of income tax benefit of 3.2																																																																			-5,100,000
loss from discontinued operations, net of income tax benefit of 52.0 for the thirteen weeks and 82.1 for the thirty-nine weeks																																																																				-82,800,000
loss from discontinued operations, net of tax benefit of 30.1 million																																																																					-48,700,000
earnings before income tax provision																																																																						1,239,200,000	1,338,600,000	1,143,600,000	1,203,900,000	672,600,000
selling, general and administrative expenses																																																																										2,403,900,000
depreciation and amortization																																																																										208,800,000

Balance Sheets:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2012-03-31	2011-09-30	2011-06-30	2011-03-31	2010-09-30	2010-06-30	2010-03-31	2009-09-30	2009-06-30	2009-03-31	2008-09-27	2008-06-28	2008-03-29	2007-12-29	2007-09-29	2007-06-30	2007-03-31

assets:
cash and cash equivalents	9,542,000,000	8,453,000,000	9,098,000,000	11,787,000,000	10,076,000,000	8,586,000,000	6,875,000,000	12,507,000,000	9,801,000,000	8,196,000,000	13,043,000,000	13,807,000,000	14,618,000,000	12,945,000,000	17,197,000,000	12,116,000,000	8,442,000,000	9,408,000,000	9,826,000,000	7,119,000,000	5,598,000,000	7,854,000,000	9,256,000,000	14,869,000,000	10,081,000,000	5,683,000,000	5,193,000,000	6,063,000,000	5,896,000,000	41,587,000,000	43,815,000,000	42,023,000,000	1,696,000,000	2,485,000,000	2,094,000,000	2,217,000,000	2,189,000,000	1,127,000,000	1,779,000,000	2,890,000,000	1,244,000,000	1,518,000,000	1,132,000,000	1,612,000,000	2,766,000,000	1,505,000,000	1,174,000,000	1,551,000,000	1,233,000,000	1,823,000,000	2,211,000,000	1,707,000,000	2,228,000,000	2,162,000,000	979,000,000	1,107,000,000	1,047,000,000	1,130,600,000	1,225,300,000	997,400,000	1,282,300,000	615,700,000	818,200,000	1,056,600,000	727,100,000	812,300,000	710,700,000
investments	2,260,000,000	2,145,000,000	2,134,000,000	2,386,000,000	2,578,000,000	2,407,000,000	2,805,000,000	3,755,000,000	3,288,000,000	3,259,000,000	3,145,000,000	3,080,000,000	3,102,000,000	2,778,000,000	2,792,000,000	2,877,000,000	2,900,000,000	3,117,000,000	3,015,000,000	3,006,000,000	3,190,000,000	3,000,000,000	2,831,000,000	2,596,000,000	2,632,000,000	2,373,000,000	2,334,000,000	2,462,000,000	2,426,000,000
accounts receivable	40,992,000,000	39,779,000,000	43,857,000,000	40,651,000,000	39,625,000,000	36,469,000,000	36,179,000,000	32,385,000,000	32,217,000,000	35,227,000,000	32,927,000,000	29,546,000,000	28,331,000,000	27,276,000,000	26,317,000,000	27,233,000,000	26,451,000,000	24,431,000,000	25,283,000,000	24,164,000,000	23,855,000,000	21,742,000,000	23,816,000,000	22,520,000,000	23,037,000,000	19,617,000,000	19,789,000,000	18,174,000,000	19,509,000,000	14,837,000,000	14,158,000,000	13,964,000,000	13,181,000,000	12,440,000,000	12,274,000,000	12,114,000,000	13,625,000,000	13,183,000,000	13,025,000,000	12,804,000,000	10,892,000,000	10,162,000,000	10,828,000,000	9,533,000,000	9,086,000,000	8,035,000,000	7,093,000,000	6,635,000,000	6,407,000,000	6,124,000,000	6,109,000,000	5,901,000,000	5,892,000,000	5,348,000,000	5,111,000,000	5,101,000,000	5,149,000,000	5,692,900,000	5,519,800,000	5,358,200,000	4,799,500,000	4,457,700,000	4,623,500,000	4,579,600,000	4,512,900,000	4,283,700,000	4,485,400,000
inventories	17,770,000,000	19,246,000,000	18,962,000,000	17,447,000,000	17,385,000,000	18,107,000,000	17,649,000,000	16,068,000,000	16,346,000,000	18,025,000,000	17,954,000,000	17,291,000,000	18,263,000,000	19,090,000,000	18,058,000,000	17,375,000,000	18,160,000,000	17,760,000,000	17,399,000,000	16,979,000,000	17,618,000,000	18,496,000,000	17,478,000,000	16,519,000,000	16,976,000,000	17,516,000,000	16,028,000,000	15,511,000,000	15,448,000,000	14,818,000,000	14,922,000,000	14,824,000,000	15,296,000,000	14,147,000,000	14,271,000,000	14,306,000,000	14,348,000,000	14,177,000,000	13,912,000,000	13,282,000,000	12,384,000,000	12,231,000,000	11,613,000,000	11,360,000,000	11,188,000,000	10,825,000,000	10,578,000,000	10,592,000,000	10,487,000,000	10,428,000,000	10,677,000,000	10,379,000,000	10,111,000,000	10,181,000,000	10,585,000,000	10,389,000,000	10,275,000,000	9,975,900,000	9,400,500,000	9,052,400,000	8,345,400,000	8,001,400,000	7,989,300,000	8,008,200,000	7,891,600,000	7,749,000,000	7,427,100,000
other current assets	4,253,000,000	5,091,000,000	3,058,000,000	3,378,000,000	3,527,000,000	3,076,000,000	3,835,000,000	5,237,000,000	5,821,000,000	3,151,000,000	3,074,000,000	3,412,000,000	3,767,000,000	2,685,000,000	2,479,000,000	2,541,000,000	5,530,000,000	5,292,000,000	5,319,000,000	5,291,000,000	5,458,000,000	5,277,000,000	5,830,000,000	6,002,000,000	6,232,000,000	5,113,000,000	4,841,000,000	4,691,000,000	4,578,000,000	634,000,000	799,000,000	868,000,000	945,000,000	776,000,000	690,000,000	735,000,000	703,000,000	881,000,000	612,000,000	579,000,000	732,000,000	594,000,000	644,000,000	554,000,000	409,000,000	401,000,000	413,000,000	340,000,000	212,000,000	384,000,000	351,000,000	502,000,000	327,000,000	174,000,000	181,000,000	171,000,000	179,000,000	169,500,000	220,800,000	261,000,000	181,400,000	170,200,000	141,000,000	148,100,000	146,300,000	146,700,000	153,700,000
total current assets	74,817,000,000	74,714,000,000	77,109,000,000	75,649,000,000	73,191,000,000	68,645,000,000	67,343,000,000	69,952,000,000	67,473,000,000	67,858,000,000	70,143,000,000	67,756,000,000	68,706,000,000	65,682,000,000	68,341,000,000	62,142,000,000	61,483,000,000	60,008,000,000	60,842,000,000	56,559,000,000	55,719,000,000	56,369,000,000	59,211,000,000	62,506,000,000	58,958,000,000	50,302,000,000	48,185,000,000	46,901,000,000	47,857,000,000	71,981,000,000	73,790,000,000	71,798,000,000	31,229,000,000	29,923,000,000	29,404,000,000	29,457,000,000	30,939,000,000	29,448,000,000	29,413,000,000	30,753,000,000	26,401,000,000	25,622,000,000	25,337,000,000	24,138,000,000	24,460,000,000	21,432,000,000	19,869,000,000	19,727,000,000	18,879,000,000	19,299,000,000	19,891,000,000	18,938,000,000	19,065,000,000	18,380,000,000	17,339,000,000	17,270,000,000	17,155,000,000	17,397,900,000	16,771,600,000	16,088,600,000	14,968,800,000	13,605,400,000	13,914,200,000	14,149,400,000	13,735,400,000	13,530,400,000	13,232,100,000
long-term investments	32,407,000,000	32,669,000,000	31,553,000,000	29,858,000,000	28,906,000,000	28,934,000,000	28,939,000,000	25,028,000,000	24,074,000,000	23,019,000,000	21,667,000,000	22,114,000,000	21,612,000,000	21,096,000,000	20,565,000,000	21,124,000,000	22,595,000,000	23,025,000,000	22,370,000,000	22,136,000,000	21,025,000,000	20,812,000,000	20,216,000,000	18,594,000,000	16,840,000,000	17,314,000,000	17,342,000,000	16,973,000,000	16,410,000,000
property and equipment	13,037,000,000	13,083,000,000	12,838,000,000	12,825,000,000	12,856,000,000	12,993,000,000	12,728,000,000	13,032,000,000	13,037,000,000	13,183,000,000	13,022,000,000	13,001,000,000	12,872,000,000	12,873,000,000	12,626,000,000	12,764,000,000	12,844,000,000	12,896,000,000	12,771,000,000	12,664,000,000	12,611,000,000	12,606,000,000	12,349,000,000	12,221,000,000	12,146,000,000	12,044,000,000	11,651,000,000	11,483,000,000	11,348,000,000	10,419,000,000	10,249,000,000	10,144,000,000	10,292,000,000	9,914,000,000	10,073,000,000	10,057,000,000	9,901,000,000	9,981,000,000	9,862,000,000	9,494,000,000	9,019,000,000	8,871,000,000	8,694,000,000	8,820,000,000	8,676,000,000	8,749,000,000	8,708,000,000	8,556,000,000	8,369,000,000	8,614,000,000	8,517,000,000	8,642,000,000	8,483,000,000	8,350,000,000	8,356,000,000	8,248,000,000	8,044,000,000	8,277,400,000	8,119,700,000	8,325,400,000	6,489,500,000	6,305,100,000	6,021,500,000	5,852,800,000	6,075,100,000	5,870,700,000	5,675,200,000
operating lease right-of-use assets	14,741,000,000	14,973,000,000	15,271,000,000	15,512,000,000	15,704,000,000	15,944,000,000	16,231,000,000	16,901,000,000	17,045,000,000	17,252,000,000	17,564,000,000	17,703,000,000	17,660,000,000	17,872,000,000	18,270,000,000	18,562,000,000	18,801,000,000	19,122,000,000	20,462,000,000	20,476,000,000	20,542,000,000	20,729,000,000	20,484,000,000	20,571,000,000	20,672,000,000	20,860,000,000	20,757,000,000	20,865,000,000	20,992,000,000
goodwill	85,478,000,000	85,478,000,000	85,478,000,000	91,203,000,000	91,203,000,000	91,272,000,000	91,272,000,000	91,272,000,000	91,272,000,000	91,272,000,000	91,261,000,000	91,260,000,000	84,057,000,000	78,150,000,000	78,086,000,000	78,560,000,000	79,060,000,000	79,121,000,000	79,121,000,000	79,552,000,000	79,552,000,000	79,552,000,000	79,579,000,000	80,057,000,000	79,993,000,000	79,749,000,000	79,548,000,000	79,485,000,000	79,075,000,000	34,216,000,000	34,220,000,000	38,115,000,000	38,451,000,000	38,169,000,000	38,130,000,000	38,263,000,000	38,214,000,000	38,190,000,000	38,115,000,000	37,135,000,000	28,122,000,000	28,123,000,000	28,151,000,000	28,126,000,000	28,139,000,000	26,550,000,000	26,554,000,000	26,575,000,000	26,422,000,000	26,425,000,000	26,431,000,000	26,506,000,000	26,697,000,000	25,666,000,000	25,673,000,000	25,672,000,000	25,674,000,000	25,622,100,000	25,483,800,000	25,491,400,000	23,925,000,000	23,926,000,000	23,922,100,000	23,922,300,000	23,424,700,000	23,472,100,000	28,533,200,000
intangible assets	25,070,000,000	25,508,000,000	25,984,000,000	26,224,000,000	26,570,000,000	27,323,000,000	27,817,000,000	28,311,000,000	28,770,000,000	29,234,000,000	29,624,000,000	30,118,000,000	26,368,000,000	24,754,000,000	25,157,000,000	28,135,000,000	28,543,000,000	29,026,000,000	29,545,000,000	30,080,000,000	30,639,000,000	31,142,000,000	31,697,000,000	32,225,000,000	32,727,000,000	33,121,000,000	33,655,000,000	34,163,000,000	35,147,000,000	13,166,000,000	13,322,000,000	13,388,000,000	13,630,000,000	13,303,000,000	13,354,000,000	13,390,000,000	13,567,000,000	13,639,000,000	13,750,000,000	13,504,000,000	9,683,000,000	9,759,000,000	9,854,000,000	9,906,000,000	9,986,000,000	9,587,000,000	9,657,000,000	9,738,000,000	9,801,000,000	9,891,000,000	9,799,000,000	9,947,000,000	10,022,000,000	9,692,000,000	9,876,000,000	9,949,000,000	10,037,000,000	10,204,300,000	10,296,800,000	10,365,300,000	10,197,200,000	10,271,200,000	10,344,300,000	10,429,600,000	11,288,900,000	11,377,800,000	3,304,800,000
other assets	7,424,000,000	5,119,000,000	5,160,000,000	5,214,000,000	5,231,000,000	4,793,000,000	4,763,000,000	4,798,000,000	4,801,000,000	4,660,000,000	4,825,000,000	4,852,000,000	4,824,000,000	4,620,000,000	4,849,000,000	4,852,000,000	4,877,000,000	4,714,000,000	4,694,000,000	4,817,000,000	4,826,000,000	4,624,000,000	4,569,000,000	4,682,000,000	4,748,000,000	4,600,000,000	4,385,000,000	4,763,000,000	4,865,000,000	1,724,000,000	1,709,000,000	1,694,000,000	1,529,000,000	1,544,000,000	1,564,000,000	1,503,000,000	1,535,000,000	1,490,000,000	1,494,000,000	1,476,000,000	1,443,000,000	1,555,000,000	1,540,000,000	1,603,000,000	1,561,000,000	1,487,000,000	1,496,000,000	1,472,000,000	1,325,000,000	1,360,000,000	1,368,000,000	1,218,000,000	1,220,000,000	740,000,000	469,000,000	385,000,000	374,000,000	377,600,000	364,100,000	385,400,000	371,000,000	359,300,000	364,900,000	367,800,000	367,500,000	355,100,000	290,500,000
total assets	252,974,000,000	253,538,000,000	255,327,000,000	258,343,000,000	255,585,000,000	253,215,000,000	252,427,000,000	252,481,000,000	249,743,000,000	249,728,000,000	251,306,000,000	250,071,000,000	239,330,000,000	228,275,000,000	231,212,000,000	230,279,000,000	232,873,000,000	232,999,000,000	234,891,000,000	231,164,000,000	229,606,000,000	230,715,000,000	232,898,000,000	235,495,000,000	230,639,000,000	222,449,000,000	220,113,000,000	218,904,000,000	219,768,000,000	131,506,000,000	133,290,000,000	135,139,000,000	95,131,000,000	92,853,000,000	92,525,000,000	92,670,000,000	94,156,000,000	92,748,000,000	92,634,000,000	92,362,000,000	74,668,000,000	73,930,000,000	73,576,000,000	72,593,000,000	72,822,000,000	67,805,000,000	66,284,000,000	66,068,000,000	64,796,000,000	65,589,000,000	66,006,000,000	65,251,000,000	65,487,000,000	62,828,000,000	61,713,000,000	61,524,000,000	61,284,000,000	61,879,300,000	61,036,000,000	60,656,100,000	55,951,500,000	54,467,000,000	54,567,000,000	54,721,900,000	54,891,600,000	54,606,100,000	51,035,800,000
liabilities:
accounts payable	16,922,000,000	17,641,000,000	17,764,000,000	17,258,000,000	16,534,000,000	15,892,000,000	15,713,000,000	14,416,000,000	13,717,000,000	14,897,000,000	14,874,000,000	13,367,000,000	12,527,000,000	14,838,000,000	13,925,000,000	13,238,000,000	12,738,000,000	12,544,000,000	12,696,000,000	11,052,000,000	10,804,000,000	11,138,000,000	11,677,000,000	9,919,000,000	10,223,000,000	10,492,000,000	9,442,000,000	9,160,000,000	8,290,000,000	8,813,000,000	8,570,000,000	7,741,000,000	8,863,000,000	7,899,000,000	7,874,000,000	7,344,000,000	7,584,000,000	7,351,000,000	7,361,000,000	7,064,000,000	6,370,000,000	6,431,000,000	6,033,000,000	5,780,000,000	5,638,000,000	5,412,000,000	5,178,000,000	5,506,000,000	5,091,000,000	4,903,000,000	5,240,000,000	4,387,000,000	4,446,000,000	4,354,000,000	4,162,000,000	3,867,000,000	4,043,000,000	3,963,200,000	3,599,900,000	3,566,300,000	3,284,400,000	3,287,000,000	3,405,000,000	3,593,000,000	3,414,200,000	3,352,300,000	3,371,100,000
pharmacy claims and discounts payable	26,149,000,000	26,344,000,000	27,085,000,000	26,338,000,000	25,797,000,000	24,166,000,000	23,917,000,000	24,188,000,000	22,289,000,000	22,874,000,000	21,497,000,000	20,417,000,000	20,047,000,000	19,423,000,000	19,161,000,000	18,393,000,000	18,572,000,000	17,330,000,000	17,895,000,000	17,225,000,000	16,282,000,000	15,795,000,000	15,722,000,000	15,541,000,000	15,449,000,000	13,601,000,000	13,099,000,000	11,937,000,000	11,827,000,000
health care costs payable	15,518,000,000	15,399,000,000	16,098,000,000	15,271,000,000	15,112,000,000	15,064,000,000	15,237,000,000	13,885,000,000	14,368,000,000	12,049,000,000	12,550,000,000	11,998,000,000	10,895,000,000	10,406,000,000	10,351,000,000	10,400,000,000	10,260,000,000	8,808,000,000	8,877,000,000	8,414,000,000	8,272,000,000	7,936,000,000	7,593,000,000	7,362,000,000	7,585,000,000	6,879,000,000	7,014,000,000	6,889,000,000	6,701,000,000
accrued expenses and other current liabilities	22,258,000,000	22,387,000,000	23,415,000,000	23,101,000,000	22,369,000,000	20,810,000,000
other insurance liabilities	1,075,000,000	1,116,000,000	1,096,000,000	1,088,000,000	1,570,000,000	1,183,000,000	1,051,000,000	1,041,000,000	1,158,000,000	1,141,000,000	4,748,000,000	4,866,000,000	4,974,000,000	1,140,000,000	4,561,000,000	1,197,000,000	1,387,000,000	1,303,000,000	1,287,000,000	1,375,000,000	1,534,000,000	1,557,000,000	1,527,000,000	1,644,000,000	1,774,000,000	1,830,000,000	1,790,000,000	1,788,000,000	1,937,000,000
current portion of operating lease liabilities	1,904,000,000	1,737,000,000	1,909,000,000	1,906,000,000	1,909,000,000	1,751,000,000	1,912,000,000	1,911,000,000	1,906,000,000	1,741,000,000	1,741,000,000	1,706,000,000	1,679,000,000	1,678,000,000	1,687,000,000	1,854,000,000	1,849,000,000	1,646,000,000	1,809,000,000	1,791,000,000	1,786,000,000	1,638,000,000	1,789,000,000	1,766,000,000	1,762,000,000	1,596,000,000	1,798,000,000	1,793,000,000	1,803,000,000
current portion of long-term debt	2,580,000,000	4,068,000,000	4,081,000,000	6,160,000,000	4,411,000,000	3,624,000,000	4,910,000,000	3,731,000,000	3,731,000,000	2,772,000,000	2,132,000,000	1,402,000,000	1,778,000,000	1,778,000,000	1,363,000,000	4,019,000,000	4,217,000,000	4,205,000,000	1,561,000,000	60,000,000	2,422,000,000	5,440,000,000	5,443,000,000	8,192,000,000	5,828,000,000	3,781,000,000	3,778,000,000	3,894,000,000	3,893,000,000	2,139,000,000	3,540,000,000	3,542,000,000	3,545,000,000	2,293,000,000	42,000,000	43,000,000	783,000,000	2,291,000,000	1,202,000,000	451,000,000	24,000,000	573,000,000	572,000,000	1,119,000,000	565,000,000	572,000,000	18,000,000	12,000,000	5,000,000	5,000,000	5,000,000	71,000,000	916,000,000	806,000,000	1,104,000,000	655,000,000	2,404,000,000	2,103,900,000	2,403,600,000	651,400,000	697,400,000	47,300,000	47,300,000	47,200,000	340,200,000	340,100,000	842,600,000
total current liabilities	86,406,000,000	88,692,000,000	92,695,000,000	94,162,000,000	88,961,000,000	84,609,000,000	84,627,000,000	81,386,000,000	83,319,000,000	79,189,000,000	81,553,000,000	79,206,000,000	75,054,000,000	69,736,000,000	72,409,000,000	68,457,000,000	69,780,000,000	67,807,000,000	64,709,000,000	59,311,000,000	60,104,000,000	62,017,000,000	62,044,000,000	63,694,000,000	59,560,000,000	53,303,000,000	52,544,000,000	49,376,000,000	50,631,000,000	29,460,000,000	31,493,000,000	30,248,000,000	30,648,000,000	28,513,000,000	26,857,000,000	27,288,000,000	26,741,000,000	26,569,000,000	24,537,000,000	21,434,000,000	20,386,000,000	19,713,000,000	18,213,000,000	16,629,000,000	16,213,000,000	15,098,000,000	12,690,000,000	13,195,000,000	13,263,000,000	13,136,000,000	13,412,000,000	12,350,000,000	11,752,000,000	11,465,000,000	11,674,000,000	11,459,000,000	12,337,000,000	12,700,400,000	12,763,800,000	11,498,800,000	9,883,500,000	8,810,800,000	9,780,100,000	10,766,300,000	9,082,800,000	9,515,600,000	12,611,300,000
long-term operating lease liabilities	13,330,000,000	13,643,000,000	14,007,000,000	14,328,000,000	14,594,000,000	14,899,000,000	15,258,000,000	15,537,000,000	15,742,000,000	16,034,000,000	16,441,000,000	16,609,000,000	16,571,000,000	16,800,000,000	17,174,000,000	17,502,000,000	17,786,000,000	18,177,000,000	18,456,000,000	18,509,000,000	18,587,000,000	18,757,000,000	18,489,000,000	18,612,000,000	18,739,000,000	18,926,000,000	18,826,000,000	18,849,000,000	18,961,000,000
long-term debt	60,531,000,000	60,502,000,000	60,508,000,000	57,290,000,000	59,040,000,000	60,527,000,000	59,824,000,000	62,643,000,000	57,694,000,000	58,638,000,000	59,782,000,000	61,419,000,000	56,450,000,000	50,476,000,000	50,848,000,000	50,797,000,000	52,063,000,000	51,971,000,000	56,832,000,000	59,294,000,000	59,270,000,000	59,207,000,000	61,552,000,000	63,481,000,000	65,735,000,000	64,699,000,000	64,206,000,000	66,941,000,000	67,888,000,000	60,747,000,000	61,569,000,000	61,552,000,000	22,181,000,000	23,386,000,000	25,622,000,000	25,622,000,000	25,610,000,000	25,600,000,000	26,267,000,000	26,771,000,000	11,633,000,000	11,689,000,000	11,709,000,000	12,252,000,000	12,845,000,000	8,819,000,000	9,358,000,000	9,352,000,000	9,210,000,000	9,208,000,000	9,206,000,000	10,167,000,000	10,168,000,000	8,669,000,000	8,653,000,000	9,454,000,000	8,454,000,000	8,756,200,000	7,305,200,000	9,056,300,000	8,047,500,000	8,348,300,000	8,349,000,000	8,349,700,000	8,395,000,000	8,395,600,000	2,895,400,000
deferred income taxes	3,771,000,000	3,832,000,000	3,547,000,000	3,603,000,000	3,664,000,000	3,806,000,000	3,632,000,000	4,052,000,000	4,184,000,000	4,311,000,000	4,250,000,000	4,588,000,000	4,095,000,000	3,880,000,000	3,508,000,000	5,450,000,000	5,829,000,000	6,270,000,000	6,329,000,000	6,557,000,000	6,610,000,000	6,794,000,000	7,253,000,000	7,136,000,000	7,121,000,000	7,294,000,000	7,279,000,000	7,375,000,000	7,540,000,000	3,052,000,000	3,054,000,000	3,058,000,000	2,996,000,000	4,442,000,000	4,210,000,000	4,214,000,000	4,254,000,000	4,260,000,000	4,232,000,000	1,077,000,000	989,000,000	1,001,000,000	1,042,000,000	979,000,000	929,000,000	558,000,000	606,000,000	604,000,000	535,000,000	535,000,000	538,000,000	444,000,000	502,000,000	509,000,000	479,000,000	498,000,000	501,000,000	424,300,000	405,200,000	419,600,000	360,200,000	360,400,000	342,200,000	329,400,000	430,000,000	415,200,000	427,700,000
other long-term insurance liabilities	4,592,000,000	4,716,000,000	4,767,000,000	4,769,000,000	4,873,000,000	4,902,000,000	5,162,000,000	5,039,000,000	5,178,000,000	5,459,000,000	5,333,000,000	5,659,000,000	5,678,000,000	6,108,000,000	6,175,000,000	6,287,000,000	6,363,000,000	6,402,000,000	6,551,000,000	6,734,000,000	6,870,000,000	7,007,000,000	7,135,000,000	7,270,000,000	7,338,000,000	7,436,000,000	7,557,000,000	7,965,000,000	8,052,000,000
other long-term liabilities	6,707,000,000	4,777,000,000	4,759,000,000	4,782,000,000	5,419,000,000	5,431,000,000	5,484,000,000	5,526,000,000	6,205,000,000	6,211,000,000	6,237,000,000	6,321,000,000	6,671,000,000	6,732,000,000	6,769,000,000	2,140,000,000	2,242,000,000	1,904,000,000	2,310,000,000	2,314,000,000	2,309,000,000	2,351,000,000	2,520,000,000	2,308,000,000	2,117,000,000	2,162,000,000	2,178,000,000	2,528,000,000	2,616,000,000	1,625,000,000	1,563,000,000	1,604,000,000	1,611,000,000	1,644,000,000	1,689,000,000	1,704,000,000	1,597,000,000	1,553,000,000	1,567,000,000	1,528,000,000	1,490,000,000	1,513,000,000	1,494,000,000	1,489,000,000	1,499,000,000	1,563,000,000	1,534,000,000	1,538,000,000	1,513,000,000	1,438,000,000	1,431,000,000	1,348,000,000	1,343,000,000	1,032,000,000	1,061,000,000	1,070,000,000	1,108,000,000	1,152,300,000	1,108,300,000	1,108,300,000	839,100,000	860,000,000	855,900,000	857,900,000	887,900,000	897,600,000	903,500,000
total liabilities	175,337,000,000	178,156,000,000	182,217,000,000	180,792,000,000	178,475,000,000	177,485,000,000	177,321,000,000	177,370,000,000	175,593,000,000	173,092,000,000	176,796,000,000	177,069,000,000	167,750,000,000	156,960,000,000	160,201,000,000	154,773,000,000	158,733,000,000	157,618,000,000	160,273,000,000	157,599,000,000	158,442,000,000	161,014,000,000	163,786,000,000	167,140,000,000	165,165,000,000	158,279,000,000	157,180,000,000	157,305,000,000	159,762,000,000	94,884,000,000	97,679,000,000	96,462,000,000																										26,204,400,000
shareholders’ equity:
preferred stock, par value 0.01: 0.1 shares authorized; none issued or outstanding
common stock	50,679,000,000	50,402,000,000	50,181,000,000	50,020,000,000	49,837,000,000	49,661,000,000	49,510,000,000	49,371,000,000	49,209,000,000	48,992,000,000	48,829,000,000	48,649,000,000	48,306,000,000	48,193,000,000	48,047,000,000	47,874,000,000	47,677,000,000	47,377,000,000	47,133,000,000	46,995,000,000	46,727,000,000	46,513,000,000	46,388,000,000	46,276,000,000	46,180,000,000	45,972,000,000	45,854,000,000	45,719,000,000	45,615,000,000	17,000,000	17,000,000	17,000,000	17,000,000	17,000,000	17,000,000	17,000,000													17,000,000	17,000,000	16,000,000	16,000,000	16,000,000	16,000,000	16,000,000	16,000,000	16,000,000	16,100,000	16,000,000	16,000,000	16,000,000	16,000,000	16,000,000	15,900,000	15,800,000	15,700,000	15,600,000
treasury stock	-36,706,000,000	-36,790,000,000	-36,776,000,000	-36,849,000,000	-36,735,000,000	-36,818,000,000	-36,813,000,000	-36,919,000,000	-36,773,000,000	-33,838,000,000	-33,831,000,000	-33,933,000,000	-33,802,000,000	-31,858,000,000	-30,326,000,000	-30,412,000,000	-30,145,000,000	-28,173,000,000	-28,166,000,000	-28,252,000,000	-28,102,000,000	-28,178,000,000	-28,164,000,000	-28,235,000,000	-28,182,000,000	-28,235,000,000	-28,207,000,000	-28,257,000,000	-28,221,000,000	-37,702,000,000	-37,749,000,000	-37,716,000,000	-37,765,000,000	-37,764,000,000	-37,414,000,000	-36,306,000,000													-15,937,000,000	-13,945,000,000	-12,752,000,000	-11,500,000,000	-9,956,000,000	-9,449,000,000	-9,029,000,000	-9,073,000,000	-8,454,000,000	-6,669,100,000	-5,182,500,000	-5,180,900,000	-5,824,400,000	-5,869,600,000	-5,854,600,000	-5,620,400,000	-3,125,700,000	-3,168,400,000	-305,200,000
retained earnings	63,282,000,000	61,196,000,000	59,107,000,000	63,936,000,000	63,768,000,000	62,837,000,000	62,038,000,000	62,797,000,000	61,873,000,000	61,604,000,000	60,343,000,000	58,868,000,000	57,753,000,000	56,145,000,000	54,571,000,000	58,710,000,000	56,488,000,000	54,906,000,000	54,264,000,000	53,331,000,000	51,203,000,000	49,640,000,000	49,328,000,000	48,768,000,000	46,455,000,000	45,108,000,000	44,017,000,000	43,136,000,000	41,859,000,000	41,843,000,000	40,965,000,000	44,040,000,000	43,556,000,000	40,779,000,000	40,005,000,000	39,419,000,000	37,732,000,000	36,647,000,000	36,182,000,000	34,398,000,000	33,544,000,000	32,667,000,000	30,845,000,000	30,221,000,000	29,297,000,000	27,551,000,000	26,573,000,000	25,728,000,000	24,123,000,000	23,324,000,000	22,566,000,000	21,192,000,000	20,491,000,000	19,845,000,000	18,396,000,000	17,705,000,000	17,004,000,000	15,412,700,000	14,501,400,000	13,726,500,000	12,245,700,000	11,608,300,000	10,919,700,000	10,287,000,000	9,573,800,000	8,972,500,000	8,341,000,000
accumulated other comprehensive income	201,000,000	406,000,000	416,000,000	272,000,000	59,000,000		209,000,000							-1,465,000,000	-1,609,000,000	-988,000,000	-190,000,000	965,000,000	1,077,000,000	1,170,000,000	1,022,000,000	1,414,000,000	1,255,000,000	1,213,000,000	687,000,000	1,019,000,000	950,000,000	684,000,000	433,000,000	129,000,000	141,000,000	172,000,000	-165,000,000	-147,000,000	-306,000,000	-296,000,000	-319,000,000	-317,000,000	-339,000,000	-316,000,000	-255,000,000	-264,000,000	-160,000,000	-132,000,000
total cvs health shareholders’ equity	77,456,000,000	75,214,000,000	72,928,000,000	77,379,000,000	76,929,000,000	75,560,000,000	74,944,000,000	74,930,000,000	73,968,000,000	76,461,000,000	74,337,000,000	72,726,000,000	71,382,000,000	71,015,000,000	70,683,000,000	75,184,000,000	73,830,000,000	75,075,000,000	74,308,000,000	73,244,000,000	70,850,000,000	69,389,000,000	68,807,000,000	68,022,000,000	65,140,000,000	63,864,000,000	62,614,000,000	61,282,000,000	59,686,000,000	36,618,000,000	35,607,000,000	38,673,000,000	37,691,000,000	34,863,000,000	34,142,000,000	33,837,000,000	35,949,000,000	34,760,000,000	36,025,000,000	37,174,000,000	37,127,000,000	36,990,000,000
noncontrolling interests	181,000,000	168,000,000	182,000,000	172,000,000	181,000,000	170,000,000	162,000,000	181,000,000	182,000,000	175,000,000	173,000,000	276,000,000	198,000,000	300,000,000	328,000,000	322,000,000	310,000,000	306,000,000	310,000,000	321,000,000	314,000,000	312,000,000	305,000,000	333,000,000	334,000,000	306,000,000	319,000,000	317,000,000	320,000,000	4,000,000	4,000,000
total shareholders’ equity	77,637,000,000	75,382,000,000	73,110,000,000	77,551,000,000	77,110,000,000	75,730,000,000	75,106,000,000	75,111,000,000	74,150,000,000	76,636,000,000	74,510,000,000	73,002,000,000	71,580,000,000	71,315,000,000	71,011,000,000	75,506,000,000	74,140,000,000	75,381,000,000	74,618,000,000	73,565,000,000	71,164,000,000	69,701,000,000	69,112,000,000	68,355,000,000	65,474,000,000	64,170,000,000	62,933,000,000	61,599,000,000	60,006,000,000	36,622,000,000	35,611,000,000	38,677,000,000	37,695,000,000	34,868,000,000	34,147,000,000	33,842,000,000	35,954,000,000	34,766,000,000	36,031,000,000	37,180,000,000	37,133,000,000	36,995,000,000	38,109,000,000	38,132,000,000	38,212,000,000	38,534,000,000	38,906,000,000	38,209,000,000	36,916,000,000	37,913,000,000	38,053,000,000	37,487,000,000	38,244,000,000	37,919,000,000	36,637,000,000	35,872,000,000	35,694,000,000	35,674,900,000	36,151,600,000	35,289,200,000	33,735,800,000	33,010,200,000	32,151,800,000	31,321,900,000	32,785,700,000	32,024,900,000	34,031,400,000
total liabilities and shareholders’ equity	252,974,000,000	253,538,000,000	255,327,000,000	258,343,000,000	255,585,000,000	253,215,000,000	252,427,000,000	252,481,000,000	249,743,000,000	249,728,000,000	251,306,000,000	250,071,000,000	239,330,000,000	228,275,000,000	231,212,000,000	230,279,000,000	232,873,000,000	232,999,000,000	234,891,000,000	231,164,000,000	229,606,000,000	230,715,000,000	232,898,000,000	235,495,000,000	230,639,000,000	222,449,000,000	220,113,000,000	218,904,000,000	219,768,000,000	131,506,000,000	133,290,000,000	135,139,000,000	95,131,000,000	92,853,000,000	92,525,000,000	92,670,000,000	94,156,000,000	92,748,000,000	92,634,000,000	92,362,000,000	74,668,000,000	73,930,000,000	73,576,000,000	72,593,000,000	72,822,000,000	67,805,000,000	66,284,000,000	66,068,000,000	64,796,000,000	65,589,000,000	66,006,000,000	65,251,000,000	65,487,000,000	62,828,000,000	61,713,000,000	61,524,000,000	61,284,000,000	61,879,300,000	61,036,000,000	60,656,100,000	55,951,500,000	54,467,000,000	54,567,000,000	54,721,900,000	54,891,600,000	54,606,100,000	51,035,800,000
separate accounts assets		1,994,000,000	1,934,000,000	1,858,000,000	1,924,000,000	3,311,000,000	3,334,000,000	3,187,000,000	3,271,000,000	3,250,000,000	3,200,000,000	3,267,000,000	3,231,000,000	3,228,000,000	3,318,000,000	4,140,000,000	4,670,000,000	5,087,000,000	5,086,000,000	4,880,000,000	4,692,000,000	4,881,000,000	4,793,000,000	4,639,000,000	4,555,000,000	4,459,000,000	4,590,000,000	4,271,000,000	4,074,000,000
short-term debt			1,247,000,000	3,040,000,000	1,259,000,000	2,119,000,000	800,000,000		2,719,000,000	200,000,000		1,000,000,000									252,000,000				255,000,000		1,070,000,000	446,000,000	3,005,000,000				1,276,000,000	110,000,000	1,100,000,000	1,768,000,000	340,000,000	745,000,000			1,488,000,000	500,000,000	775,000,000			814,000,000		300,000,000	825,000,000	200,000,000		530,000,000		300,000,000	1,384,000,000	1,852,000,000	515,000,000	1,100,000,000	1,328,000,000	1,419,900,000	982,000,000	980,000,000	1,341,900,000	2,085,000,000	425,000,000	660,400,000	3,072,800,000
separate accounts liabilities		1,994,000,000	1,934,000,000	1,858,000,000	1,924,000,000	3,311,000,000	3,334,000,000	3,187,000,000	3,271,000,000	3,250,000,000	3,200,000,000	3,267,000,000	3,231,000,000	3,228,000,000	3,318,000,000	4,140,000,000	4,670,000,000	5,087,000,000	5,086,000,000	4,880,000,000	4,692,000,000	4,881,000,000	4,793,000,000	4,639,000,000	4,555,000,000	4,459,000,000	4,590,000,000	4,271,000,000	4,074,000,000
commitments and contingencies
accumulated other comprehensive loss						-120,000,000		-319,000,000	-341,000,000	-297,000,000	-1,004,000,000	-858,000,000	-875,000,000																																-139,000,000	-194,000,000	-198,000,000	-182,000,000	-170,000,000	-171,000,000	-171,000,000	-152,000,000	-153,000,000	-143,000,000	-133,000,000	-133,000,000	-130,000,000	-143,700,000	-141,000,000	-141,900,000	-47,200,000	-48,000,000	-48,900,000	-49,700,000	-70,100,000	-70,900,000	-71,800,000
policyholders’ funds							913,000,000	1,051,000,000	1,081,000,000	1,326,000,000	1,440,000,000	1,411,000,000	1,426,000,000	1,500,000,000	1,642,000,000	1,628,000,000	4,138,000,000	4,301,000,000	4,444,000,000	4,567,000,000	4,440,000,000	4,270,000,000	3,964,000,000	3,636,000,000	3,110,000,000	2,991,000,000	2,938,000,000	2,907,000,000	2,732,000,000
accrued expenses							20,174,000,000	21,163,000,000	22,350,000,000	22,189,000,000	22,571,000,000	22,831,000,000	21,515,000,000	18,745,000,000	19,423,000,000	17,728,000,000	16,619,000,000	17,670,000,000	16,140,000,000	14,827,000,000	14,312,000,000	14,243,000,000	14,329,000,000	15,634,000,000	13,574,000,000	12,133,000,000	11,615,000,000	10,562,000,000	10,443,000,000	6,160,000,000	7,640,000,000	7,724,000,000	6,609,000,000	8,404,000,000	8,133,000,000	8,680,000,000	8,856,000,000	7,244,000,000	7,444,000,000	6,636,000,000	5,543,000,000	5,936,000,000	5,433,000,000	4,812,000,000	5,132,000,000	3,940,000,000	3,501,000,000	3,523,000,000	3,618,000,000	4,380,000,000	4,506,000,000	4,259,000,000	3,329,000,000	3,229,000,000	2,664,000,000	2,603,000,000	2,898,000,000	2,625,500,000	2,469,000,000	2,927,400,000	2,491,500,000	2,250,900,000	2,504,600,000	2,556,800,000	2,432,000,000	2,512,300,000	2,755,900,000
assets held for sale												620,000,000	625,000,000	908,000,000	1,498,000,000
liabilities held for sale												208,000,000	213,000,000	228,000,000	296,000,000
short-term investments																														105,000,000	96,000,000	119,000,000	111,000,000	75,000,000	75,000,000	85,000,000	74,000,000	80,000,000	85,000,000	121,000,000	160,000,000	116,000,000	78,000,000	100,000,000	82,000,000	108,000,000	5,000,000	5,000,000	5,000,000	5,000,000	5,000,000	5,000,000	5,000,000	6,000,000	4,000,000	4,000,000	4,000,000	4,700,000						27,500,000	27,500,000	123,500,000	27,500,000
claims and discounts payable																														12,348,000,000	11,743,000,000	11,241,000,000	10,355,000,000	9,807,000,000	9,708,000,000	9,453,000,000	9,178,000,000	8,938,000,000	8,530,000,000	7,283,000,000	6,961,000,000	6,273,000,000	5,400,000,000	4,918,000,000	4,878,000,000	4,360,000,000	3,993,000,000	3,854,000,000	3,724,000,000	3,648,000,000	3,661,000,000	3,103,000,000	3,061,000,000	2,776,000,000	2,360,000,000	2,482,000,000	2,477,000,000	2,907,800,000	2,963,300,000	2,933,800,000	2,428,200,000	2,245,600,000	2,481,300,000	2,484,300,000	2,471,400,000	2,650,500,000	2,568,900,000
cvs health shareholders’ equity:
capital surplus																														32,360,000,000	32,264,000,000	32,191,000,000	32,079,000,000	32,009,000,000	31,871,000,000	31,034,000,000	31,541,000,000	31,454,000,000	31,254,000,000	31,005,000,000	30,840,000,000	30,235,000,000	30,310,000,000	30,186,000,000	29,985,000,000	29,653,000,000	29,532,000,000	29,302,000,000	28,914,000,000	28,744,000,000	28,450,000,000	27,987,000,000	27,902,000,000	27,706,000,000	27,443,000,000	27,413,000,000	27,314,000,000	27,114,400,000	27,013,200,000	26,925,000,000	27,250,200,000	27,205,600,000	27,019,000,000	26,831,900,000	26,569,300,000	26,451,100,000	26,224,300,000
shares held in trust: 1 share at september 30, 2018 and december 31, 2017																														-29,000,000
shares held in trust: 1 share at june 30, 2018 and december 31, 2017																															-31,000,000
shares held in trust: 1 share at march 31, 2018 and december 31, 2017																																-31,000,000
noncontrolling interest																																4,000,000	4,000,000	5,000,000	5,000,000	5,000,000	5,000,000	6,000,000	6,000,000	6,000,000	6,000,000	5,000,000	5,000,000	2,000,000	2,000,000
shares held in trust: 1 share at december 31, 2017 and december 31, 2016																																	-31,000,000
shares held in trust: 1 share at september 30, 2017 and december 31, 2016																																		-31,000,000
shares held in trust: 1 share at june 30, 2017 and december 31, 2016																																			-31,000,000
shares held in trust: 1 share at march 31, 2017 and december 31, 2016																																				-31,000,000
redeemable noncontrolling interest																																																			29,000,000	31,000,000	32,000,000	33,000,000	35,000,000	36,000,000	36,000,000
preferred stock, par value 0.01: 0.1 share authorized; none issued or outstanding
shares outstanding at september 30, 2016 and 1,699 shares issued and 1,101 shares
outstanding at december 31, 2015																																					17,000,000	17,000,000	17,000,000
2015																																					-32,991,000,000	-33,010,000,000	-31,058,000,000
shares held in trust: 1 share at september 30, 2016 and december 31, 2015																																					-31,000,000
shares outstanding at june 30, 2016 and 1,699 shares issued and 1,101 shares
shares held in trust: 1 share at june 30, 2016 and december 31, 2015																																						-31,000,000
shares outstanding at march 31, 2016 and 1,699 shares issued and 1,101 shares
shares held in trust: 1 share at march 31, 2016 and december 31, 2015																																							-31,000,000
shares outstanding at september 30, 2015 and 1,691 shares issued and 1,140 shares
outstanding at december 31, 2014																																								17,000,000	17,000,000	17,000,000
2014																																								-27,899,000,000	-26,988,000,000	-25,634,000,000
shares held in trust: 1 share at september 30, 2015 and december 31, 2014																																								-31,000,000
shares outstanding at june 30, 2015 and 1,691 shares issued and 1,140 shares
shares held in trust: 1 share at june 30, 2015 and december 31, 2014																																									-31,000,000
shares outstanding at march 31, 2015 and 1,691 shares issued and 1,140 shares
shares held in trust: 1 share at march 31, 2015 and december 31, 2014																																										-31,000,000
cvs health shareholders' equity:
shares outstanding at september 30, 2014 and 1,680 shares issued and 1,180 shares
outstanding at december 31, 2013																																											17,000,000	17,000,000	17,000,000
2013																																											-22,877,000,000	-22,131,000,000	-20,919,000,000
shares held in trust: 1 share at september 30, 2014 and december 31, 2013																																											-31,000,000
total cvs health shareholders' equity																																											38,104,000,000
cvs caremark shareholders' equity:
shares outstanding at june 30, 2014 and 1,680 shares issued and 1,180 shares
shares held in trust: 1 share at june 30, 2014 and december 31, 2013																																												-31,000,000
total cvs caremark shareholders' equity																																												38,130,000,000	38,210,000,000
shares outstanding at march 31, 2014 and 1,680 shares issued and 1,180 shares
shares held in trust: 1 share at march 31, 2014 and december 31, 2013																																													-31,000,000
shares outstanding at september 30, 2013 and 1,667 shares issued and 1,231 shares
outstanding at december 31, 2012																																														17,000,000	17,000,000	17,000,000
2012																																														-18,462,000,000	-16,987,000,000	-16,625,000,000
shares held in trust: 1 share at september 30, 2013 and december 31, 2012																																														-31,000,000
shares outstanding at june 30, 2013 and 1,667 shares issued and 1,231 shares
shares held in trust: 1 share at june 30, 2013 and december 31, 2012																																															-31,000,000
shares outstanding at march 31, 2013 and 1,667 shares issued and 1,231 shares
shares held in trust: 1 share at march 31, 2013 and december 31, 2012																																																-31,000,000
shares held in trust: 1 share at september 30, 2012 and 2 shares at december 31, 2011																																																	-31,000,000
shares held in trust: 2 shares at june 30, 2012 and december 31, 2011																																																		-56,000,000
shares held in trust: 2 shares at march 31, 2012 and december 31, 2011																																																			-56,000,000
shares held in trust: 2 shares at september 30, 2011 and december 31, 2010																																																				-56,000,000
shares held in trust: 2 shares at june 30, 2011 and december 31, 2010																																																					-56,000,000
shares held in trust: 2 shares at march 31, 2011 and december 31, 2010																																																						-56,000,000
shares held in trust: 2 shares at september 30, 2010 and december 31, 2009																																																							-56,000,000
shares held in trust: 2 shares at june 30, 2010 and december 31, 2009																																																								-56,000,000
shares held in trust: 2 shares at march 31, 2010 and december 31, 2009																																																									-56,000,000
preference stock, series one esop convertible, par value 1.00: authorized 50,000,000 shares; no issued and outstanding shares at september 30, 2009 and 3,583,000 shares issued and outstanding at december 31, 2008
shares held in trust: 1,700,000 shares																																																										-55,500,000
preference stock, series one esop convertible, par value 1.00: authorized 50,000,000 shares; no issued and outstanding shares at june 30, 2009 and 3,583,000 shares issued and outstanding at december 31, 2008
shares held in trust; 1,700,000 shares at june 30, 2009 and at december 31, 2008																																																											-55,500,000
preference stock, series one esop convertible, par value 1.00: authorized 50,000,000 shares; no issued and outstanding shares at march 31, 2009 and 3,583,000 shares issued and outstanding at december 31, 2008
shares held in trust; 1,700,000 shares at march 31, 2009 and at december 31, 2008																																																												-55,500,000
preference stock, series one esop convertible, par value 1.00: authorized 50,000,000 shares; issued and outstanding 3,658,000 shares at september 27, 2008 and 3,798,000 shares at december 29, 2007																																																													195,500,000
shares held in trust, 1,700,000 shares at september 27, 2008 and 9,224,000 shares at december 29, 2007																																																													-55,500,000
guaranteed esop obligation																																																													-44,500,000	-44,500,000	-44,500,000	-44,500,000	-82,100,000	-82,100,000	-82,100,000
preference stock, series one esop convertible, par value 1.00: authorized 50,000,000 shares; issued and outstanding 3,702,000 shares at june 28, 2008 and 3,798,000 shares at december 29, 2007																																																														197,900,000
shares held in trust, 1,700,000 shares at june 28, 2008 and 9,224,000 shares at december 29, 2008																																																														-55,500,000
preference stock, series one esop convertible, par value 1.00: authorized 50,000,000 shares; issued and outstanding 3,752,000 shares at march 29, 2008 and 3,798,000 shares at december 29, 2007																																																															200,600,000
shares held in trust, 1,700,000 shares at march 29, 2008 and 9,224,000 shares at december 29, 2007																																																															-55,500,000
preferred stock, 0.01 par value: authorized 120,619 shares; no shares issued or outstanding
preference stock, series one esop convertible, par value 1.00: authorized 50,000,000 shares; issued and outstanding 3,798,000 shares at december 29, 2007 and 3,990,000 shares at december 30, 2006																																																																203,000,000
shares held in trust, 9,224,000 shares at december 29, 2007																																																																-301,300,000
preference stock, series one esop convertible, par value 1.00: authorized 50,000,000 shares; issued and outstanding 3,853,000 shares at september 29, 2007 and 3,990,000 shares at december 30, 2006																																																																	206,000,000
shares held in trust, 9,224,000 shares at september 29, 2007																																																																	-301,300,000
preference stock, series one esop convertible, par value 1.00: authorized 50,000,000 shares; issued and outstanding 3,896,000 shares at june 30, 2007 and 3,990,000 shares at december 30, 2006																																																																		208,300,000
shares held in trust, 9,224,000 shares at june 30, 2007																																																																		-301,300,000
preference stock, series one esop convertible, par value 1.00: authorized 50,000,000 shares; issued and outstanding 3,945,000 shares at march 31, 2007 and 3,990,000 shares at december 30, 2006																																																																			210,900,000
shares held in trust, 9,224,000 shares at march 31, 2007																																																																			-301,300,000

Cashflow Statements:

Quarterly

Annual

Unit: USD	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2012-03-31	2011-09-30	2011-06-30	2011-03-31	2010-09-30	2010-06-30	2010-03-31	2009-09-30	2009-06-30	2009-03-31	2008-09-27	2008-06-28	2008-03-29	2007-12-29	2007-09-29	2007-06-30	2007-03-31

cash flows from operating activities:
cash receipts from customers	94,201,000,000	105,750,000,000	96,878,000,000	95,691,000,000	90,809,000,000	93,457,000,000	90,810,000,000	88,731,000,000	84,997,000,000	85,164,000,000	84,733,000,000	87,769,000,000	87,798,000,000	78,267,000,000	83,626,000,000	77,577,000,000	74,192,000,000	75,115,000,000	72,483,000,000	70,134,000,000	66,487,000,000	68,773,000,000	66,336,000,000	65,467,000,000	63,751,000,000	63,874,000,000	63,711,000,000	61,935,000,000	58,873,000,000	44,298,000,000	44,608,000,000	43,369,000,000	43,539,000,000	44,712,000,000	44,430,000,000	43,913,000,000	44,221,000,000	42,842,000,000	41,482,000,000	37,310,000,000	36,444,000,000	34,570,000,000	32,884,000,000	32,427,000,000	30,505,000,000	28,962,000,000	28,428,000,000	28,018,000,000	26,819,000,000	28,437,000,000	29,207,000,000
cash paid for inventory, prescriptions dispensed and health services rendered	-50,551,000,000	-58,644,000,000	-56,651,000,000	-52,765,000,000	-48,433,000,000	-52,257,000,000	-54,624,000,000	-46,021,000,000	-44,824,000,000	-55,797,000,000
insurance benefits paid	-28,398,000,000	-32,469,000,000	-29,925,000,000	-30,367,000,000	-28,477,000,000	-29,107,000,000	-27,872,000,000	-27,591,000,000	-24,894,000,000	-22,439,000,000	-20,550,000,000	-21,351,000,000	-19,757,000,000	-18,294,000,000	-17,514,000,000	-17,304,000,000	-16,616,000,000	-16,633,000,000	-15,720,000,000	-15,789,000,000	-15,456,000,000	-14,903,000,000	-13,738,000,000	-12,180,000,000	-14,303,000,000	-13,430,000,000	-12,820,000,000	-13,041,000,000	-12,951,000,000
cash paid to other suppliers and employees	-10,775,000,000	-10,262,000,000	-8,678,000,000	-9,940,000,000	-8,690,000,000	-9,888,000,000	-7,809,000,000	-11,447,000,000	-9,677,000,000	-8,697,000,000	-8,352,000,000	-7,728,000,000	-9,958,000,000	-10,294,000,000	-7,249,000,000	-6,150,000,000	-8,969,000,000	-9,812,000,000	-6,940,000,000	-6,630,000,000	-8,270,000,000	-7,578,000,000	-7,497,000,000	-6,501,000,000	-8,187,000,000	-7,521,000,000	-6,914,000,000	-7,094,000,000	-7,403,000,000	-3,834,000,000	-4,200,000,000	-4,271,000,000	-4,118,000,000	-4,230,000,000	-3,177,000,000	-3,823,000,000	-4,010,000,000	-4,121,000,000	-2,961,000,000	-3,305,000,000	-3,773,000,000	-4,162,000,000	-3,480,000,000	-3,591,000,000	-4,196,000,000	-3,308,000,000	-3,563,000,000	-3,889,000,000			-3,751,000,000			-3,342,000,000	-3,217,000,000	-3,213,000,000	-3,916,000,000	-3,510,900,000	-3,237,100,000	-3,913,500,000	-2,845,600,000	-2,949,400,000	-2,989,100,000	-5,025,100,000	-1,295,800,000	-1,937,700,000	-2,510,000,000
interest and investment income received	526,000,000	475,000,000	522,000,000	475,000,000	497,000,000	447,000,000	449,000,000	432,000,000	407,000,000	410,000,000	373,000,000	375,000,000	426,000,000	699,000,000	127,000,000	1,000,000	199,000,000	161,000,000	188,000,000	172,000,000	222,000,000	272,000,000	227,000,000	189,000,000	206,000,000	199,000,000	244,000,000	262,000,000	250,000,000
interest paid	-1,091,000,000	-462,000,000	-1,045,000,000	-472,000,000	-1,012,000,000	-518,000,000	-999,000,000	-349,000,000	-1,043,000,000	-369,000,000	-918,000,000	-358,000,000	-773,000,000	-303,000,000	-786,000,000	-368,000,000	-782,000,000	-374,000,000	-832,000,000	-387,000,000	-876,000,000	-387,000,000	-1,110,000,000	-279,000,000	-1,128,000,000	-279,000,000	-1,173,000,000	-379,000,000	-1,123,000,000	-1,199,000,000	-15,000,000	-545,000,000	-203,000,000	-330,000,000	-211,000,000	-328,000,000	-339,000,000	-237,000,000	-378,000,000	-112,000,000	-224,000,000	-87,000,000	-127,000,000	-227,000,000	-104,000,000	-102,000,000	-163,000,000	-104,000,000			-128,000,000			-150,000,000	-155,000,000	-129,000,000	-155,000,000	-125,400,000	-161,200,000	-123,000,000	-116,300,000	-142,500,000	-124,600,000	-147,300,000	-119,700,000	-91,500,000	-109,700,000
income taxes refunded	337,000,000
net cash from operating activities	4,249,000,000	3,390,000,000	796,000,000	1,897,000,000	4,556,000,000	1,860,000,000	-745,000,000	3,089,000,000	4,903,000,000	-2,636,000,000	2,716,000,000	5,908,000,000	7,438,000,000	-1,952,000,000	9,123,000,000	5,443,000,000	3,563,000,000	4,005,000,000	5,521,000,000	5,847,000,000	2,892,000,000	3,567,000,000	1,874,000,000	7,119,000,000	3,305,000,000	2,634,000,000	2,928,000,000	5,338,000,000	1,948,000,000	1,097,000,000	2,934,000,000	2,355,000,000	-136,000,000	2,611,000,000	1,999,000,000	3,533,000,000	3,925,000,000	1,611,000,000	2,412,000,000	1,820,000,000	1,037,000,000	1,984,000,000	1,645,000,000	897,000,000	2,172,000,000	1,703,000,000	902,000,000	1,640,000,000	923,000,000	1,231,000,000	2,786,000,000	1,962,000,000	1,207,000,000	1,866,000,000	1,292,000,000	652,000,000	1,060,000,000	907,400,000	551,900,000	771,300,000	786,200,000	651,300,000	740,800,000	1,357,000,000	445,500,000	719,500,000	707,700,000
capital expenditures	-849,000,000	-784,000,000	-698,000,000	-607,000,000	-743,000,000	-768,000,000	-670,000,000	-638,000,000	-705,000,000	-911,000,000	-545,000,000	-591,000,000	-984,000,000	-688,000,000	-580,000,000	-408,000,000	-1,051,000,000	-597,000,000	-608,000,000	-486,000,000	-829,000,000	-713,000,000	-534,000,000	-448,000,000	-742,000,000	-567,000,000	-601,000,000	-573,000,000	-716,000,000	-540,000,000	-430,000,000	-482,000,000	-506,000,000	-524,000,000	-431,000,000	-457,000,000	-505,000,000	-504,000,000	-598,000,000	-548,000,000	-523,000,000	-419,000,000	-545,000,000	-503,000,000	-388,000,000	-526,000,000	-486,000,000	-318,000,000	0	0	-376,000,000	0	0	-309,000,000	-513,000,000	-465,000,000	-401,000,000	-661,200,000	-624,900,000	-466,400,000	-527,900,000	-555,000,000	-400,300,000	-572,600,000	-454,700,000	-466,100,000	-311,900,000
free cash flows	3,400,000,000	2,606,000,000	98,000,000	1,290,000,000	3,813,000,000	1,092,000,000	-1,415,000,000	2,451,000,000	4,198,000,000	-3,547,000,000	2,171,000,000	5,317,000,000	6,454,000,000	-2,640,000,000	8,543,000,000	5,035,000,000	2,512,000,000	3,408,000,000	4,913,000,000	5,361,000,000	2,063,000,000	2,854,000,000	1,340,000,000	6,671,000,000	2,563,000,000	2,067,000,000	2,327,000,000	4,765,000,000	1,232,000,000	557,000,000	2,504,000,000	1,873,000,000	-642,000,000	2,087,000,000	1,568,000,000	3,076,000,000	3,420,000,000	1,107,000,000	1,814,000,000	1,272,000,000	514,000,000	1,565,000,000	1,100,000,000	394,000,000	1,784,000,000	1,177,000,000	416,000,000	1,322,000,000	923,000,000	1,231,000,000	2,410,000,000	1,962,000,000	1,207,000,000	1,557,000,000	779,000,000	187,000,000	659,000,000	246,200,000	-73,000,000	304,900,000	258,300,000	96,300,000	340,500,000	784,400,000	-9,200,000	253,400,000	395,800,000
cash flows from investing activities:
proceeds from sales and maturities of investments	4,159,000,000	2,743,000,000	2,774,000,000	3,332,000,000	3,534,000,000	2,719,000,000	3,216,000,000	2,265,000,000	2,153,000,000	2,182,000,000	1,907,000,000	1,749,000,000	1,891,000,000	1,194,000,000	1,175,000,000	1,790,000,000	2,570,000,000	1,687,000,000	1,612,000,000	1,770,000,000	2,177,000,000	2,677,000,000	1,080,000,000	1,422,000,000	1,288,000,000	1,433,000,000	1,830,000,000	1,800,000,000	1,986,000,000
purchases of investments	-4,186,000,000	-3,967,000,000	-3,859,000,000	-3,634,000,000	-3,552,000,000	-2,514,000,000	-5,896,000,000	-3,236,000,000	-3,545,000,000	-2,418,000,000	-2,126,000,000	-2,141,000,000	-2,358,000,000	-1,307,000,000	-1,429,000,000	-1,536,000,000	-3,474,000,000	-2,546,000,000	-1,847,000,000	-2,439,000,000	-3,131,000,000	-3,262,000,000	-2,689,000,000	-2,153,000,000	-1,535,000,000	-1,523,000,000	-1,949,000,000	-2,015,000,000	-2,047,000,000
purchases of property and equipment	-849,000,000	-784,000,000	-698,000,000	-607,000,000	-743,000,000	-768,000,000	-670,000,000	-638,000,000	-705,000,000	-911,000,000	-545,000,000	-591,000,000	-984,000,000	-688,000,000	-580,000,000	-408,000,000	-1,051,000,000	-597,000,000	-608,000,000	-486,000,000	-829,000,000	-713,000,000	-534,000,000	-448,000,000	-742,000,000	-567,000,000	-601,000,000	-573,000,000	-716,000,000	-540,000,000	-430,000,000	-482,000,000	-506,000,000	-524,000,000	-431,000,000	-457,000,000	-505,000,000	-504,000,000	-598,000,000	-548,000,000	-523,000,000	-419,000,000	-545,000,000	-503,000,000	-388,000,000	-526,000,000	-486,000,000	-318,000,000			-376,000,000			-309,000,000
acquisitions	-5,000,000	-7,000,000	-290,000,000	-119,000,000	-20,000,000	-10,000,000	-12,000,000	-48,000,000	-25,000,000	-120,000,000	-18,000,000	-9,380,000,000	-7,094,000,000	-8,000,000	-6,000,000	-118,000,000	-7,000,000	-11,000,000	-27,000,000	-24,000,000	-84,000,000	-38,000,000	-60,000,000	-155,000,000	-613,000,000	-83,000,000	-111,000,000	-126,000,000	-124,000,000
other	7,000,000	17,000,000	-14,000,000	4,000,000	19,000,000	26,000,000	15,000,000	32,000,000	28,000,000	25,000,000	11,000,000	1,000,000	31,000,000	11,000,000	20,000,000	85,000,000	-31,000,000	27,000,000	23,000,000				-1,000,000	1,000,000	5,000,000	26,000,000	2,000,000	4,000,000	10,000,000								-2,000,000	0	-4,000,000
net cash from investing activities	-874,000,000	-1,998,000,000	-2,087,000,000	-1,024,000,000	-762,000,000	-547,000,000	-3,347,000,000	-1,625,000,000	-2,094,000,000	-1,242,000,000	-771,000,000	-10,362,000,000	-8,514,000,000	-119,000,000	-805,000,000	-2,130,000,000	-1,993,000,000	-1,440,000,000	-847,000,000	-1,107,000,000	-1,867,000,000	-1,234,000,000	-1,370,000,000	-1,333,000,000	-1,597,000,000	-709,000,000	-829,000,000	-910,000,000	-891,000,000	-634,000,000	-621,000,000	-131,000,000	-1,324,000,000	-434,000,000	-620,000,000	-554,000,000	-421,000,000	-598,000,000	-633,000,000	-9,910,000,000	-546,000,000	-544,000,000	-349,000,000	-625,000,000	-2,560,000,000	-529,000,000	-526,000,000	-567,000,000			-443,000,000			-299,000,000	-508,000,000	-483,000,000	-397,000,000	-437,300,000	-162,200,000	-445,800,000	-410,400,000	-515,900,000	-346,800,000	-30,000,000	-346,200,000	-441,700,000	-2,263,800,000
cash flows from financing activities:
commercial paper borrowings (repayments)		-1,247,000,000	-1,793,000,000	1,780,000,000	-859,000,000	1,319,000,000	800,000,000	-2,719,000,000	2,519,000,000
repayments of long-term debt	-1,518,000,000	-20,000,000	-2,847,000,000	-19,000,000	-743,000,000	-3,067,000,000	-1,669,000,000	-19,000,000	-18,000,000	-432,000,000	-947,000,000	-1,425,000,000	-362,000,000	-16,000,000	-2,666,000,000	-1,515,000,000	-14,000,000	-2,431,000,000	-2,400,000,000	-2,374,000,000	-3,049,000,000	-5,138,000,000	-9,477,000,000	-8,000,000	-1,008,000,000	14,000,000	-6,451,000,000	-1,017,000,000	-882,000,000								-1,606,000,000			-2,348,000,000			-3,045,000,000								-52,000,000			-301,000,000	-351,000,000
dividends paid	-847,000,000	-845,000,000	-846,000,000	-866,000,000	-840,000,000	-838,000,000	-837,000,000	-858,000,000	-840,000,000	-779,000,000	-779,000,000	-795,000,000	-779,000,000	-719,000,000	-726,000,000	-740,000,000	-722,000,000	-660,000,000	-659,000,000	-650,000,000	-656,000,000	-644,000,000	-665,000,000	-663,000,000	-652,000,000	-651,000,000	-646,000,000	-657,000,000	-649,000,000	-510,000,000	-510,000,000	-508,000,000	-510,000,000	-511,000,000	-512,000,000	-516,000,000	-455,000,000	-459,000,000	-470,000,000	-391,000,000	-395,000,000	-399,000,000	-324,000,000	-322,000,000	-325,000,000	-276,000,000	-276,000,000	-277,000,000			-211,000,000			-171,000,000	-119,000,000	-119,000,000	-122,000,000	-110,100,000	-111,000,000	-109,700,000	-98,400,000	-86,200,000	-85,900,000	-101,800,000	-88,200,000	-92,100,000	-40,300,000
proceeds from exercise of stock options	103,000,000	86,000,000	117,000,000	47,000,000	144,000,000	19,000,000	114,000,000	25,000,000	203,000,000	35,000,000	122,000,000	24,000,000	96,000,000	41,000,000	162,000,000	51,000,000	297,000,000	109,000,000	110,000,000	118,000,000	212,000,000	15,000,000	83,000,000	12,000,000	154,000,000	27,000,000	72,000,000	10,000,000	101,000,000	84,000,000	23,000,000	107,000,000	15,000,000	125,000,000	68,000,000	121,000,000	83,000,000	30,000,000	92,000,000	66,000,000	85,000,000	126,000,000	112,000,000	112,000,000	154,000,000	122,000,000	159,000,000	150,000,000	159,000,000	240,000,000	278,000,000	77,000,000	157,000,000	107,000,000	26,000,000	48,000,000	97,000,000	145,100,000	36,400,000	55,000,000	34,800,000	108,800,000	170,100,000	199,500,000	121,600,000	174,400,000	56,900,000
payments for taxes related to net share settlement of equity awards	-9,000,000	-13,000,000	-20,000,000	-114,000,000	-11,000,000	-4,000,000	-5,000,000	-145,000,000	-31,000,000	-6,000,000	-7,000,000	-134,000,000	-34,000,000	-33,000,000	-8,000,000	-267,000,000	-62,000,000	-7,000,000	-2,000,000	-156,000,000	-3,000,000	-13,000,000	-7,000,000	-52,000,000	-16,000,000	-27,000,000	-5,000,000	-36,000,000	-44,000,000	-2,000,000			-1,000,000	-10,000,000	-49,000,000	-11,000,000
net cash from financing activities	-2,318,000,000	-2,032,000,000	-1,382,000,000	806,000,000	-2,332,000,000	431,000,000	-1,588,000,000	1,249,000,000	-1,227,000,000	-972,000,000	-2,697,000,000	3,626,000,000	2,726,000,000	-2,187,000,000	-3,218,000,000	-2,461,000,000	-2,650,000,000	-2,831,000,000	-1,967,000,000	-3,314,000,000	-3,244,000,000	-3,735,000,000	-6,117,000,000	-978,000,000	2,675,000,000	-1,440,000,000	-2,968,000,000	-4,258,000,000	816,000,000	-2,693,000,000	-520,000,000	38,140,000,000	670,000,000	-1,786,000,000	-1,502,000,000	-4,133,000,000	-2,442,000,000	-1,666,000,000	-2,460,000,000	9,743,000,000	-761,000,000	-2,406,000,000	-1,775,000,000	-1,423,000,000	-935,000,000	-850,000,000	-751,000,000	-897,000,000			-1,545,000,000			-832,000,000	-912,000,000	-109,000,000	-702,000,000	-564,800,000	-161,800,000	-680,500,000	290,800,000	-337,900,000	-632,400,000	-997,500,000	-184,500,000	-176,200,000	1,736,100,000
net increase in cash, cash equivalents and restricted cash	1,057,000,000	-640,000,000	-2,673,000,000	1,679,000,000	1,462,000,000	1,744,000,000	-5,680,000,000	2,713,000,000	1,582,000,000	-4,850,000,000	-752,000,000	-828,000,000	1,650,000,000	-4,258,000,000				-266,000,000	2,707,000,000	1,426,000,000	-2,219,000,000	-1,402,000,000	-5,613,000,000	4,808,000,000	4,383,000,000	485,000,000	-869,000,000	170,000,000	1,873,000,000	-2,230,000,000	1,793,000,000	40,364,000,000
cash, cash equivalents and restricted cash at the beginning of the period	8,712,000,000	0	0	0	8,884,000,000	0	0	0	8,525,000,000	0	0	0	13,305,000,000	0	0	0	12,691,000,000	2,913,000,000	0	0	8,130,000,000	0	0	0	5,954,000,000	0	0	0	4,295,000,000	0	0	1,900,000,000
cash, cash equivalents and restricted cash at the end of the period	9,769,000,000	-640,000,000	-2,673,000,000	1,679,000,000	10,346,000,000	1,744,000,000	-5,680,000,000	2,713,000,000	10,107,000,000	-4,850,000,000	-752,000,000	-828,000,000	14,955,000,000	-4,258,000,000	5,100,000,000	852,000,000	11,611,000,000	2,647,000,000	2,707,000,000	1,426,000,000	5,911,000,000	-1,402,000,000	-5,613,000,000	4,808,000,000	10,337,000,000	485,000,000	-869,000,000	170,000,000	6,168,000,000	-2,230,000,000	1,793,000,000	42,264,000,000
income taxes paid		-998,000,000	-305,000,000	-725,000,000	-138,000,000	-274,000,000	-700,000,000	-666,000,000	-63,000,000	-908,000,000	-837,000,000	-1,704,000,000	-75,000,000	-1,046,000,000	-1,183,000,000	-1,791,000,000	-96,000,000	-798,000,000	-845,000,000	-1,508,000,000	-44,000,000	-564,000,000	-2,135,000,000	-165,000,000	-65,000,000	-512,000,000	-729,000,000	-1,423,000,000	-53,000,000	-560,000,000	-1,298,000,000	-53,000,000	-869,000,000	-506,000,000	-1,477,000,000	-57,000,000	-432,000,000	-1,601,000,000	-161,000,000	-678,000,000	-1,563,000,000	-64,000,000	-838,000,000	-1,413,000,000	-70,000,000	-683,000,000	-1,414,000,000	-116,000,000			-28,000,000			-169,000,000	-549,000,000	-1,029,000,000	-207,000,000	-463,400,000	-1,036,100,000	-289,300,000	-470,700,000	-774,300,000	-13,600,000	-437,200,000	-626,800,000	-662,200,000	-54,600,000
proceeds from issuance of short-term loan										0	0
repayment of short-term loan										0	0
proceeds from issuance of long-term debt		0				2,954,000,000	0			0	0	4,947,000,000	5,951,000,000					0				2,039,000,000	3,973,000,000	0	3,946,000,000	278,000,000				0	0	39,376,000,000					0															0
repurchase of common stock						0	1,000,000	3,000,000	-3,027,000,000	1,000,000	3,000,000	2,000,000	-2,018,000,000	-1,500,000,000	0	0	-2,000,000,000																0	-400,000,000	-340,000,000	-3,621,000,000	-40,000,000	-1,894,000,000	-2,066,000,000	-937,000,000	-927,000,000	-2,007,000,000	-800,000,000	-1,200,000,000	-801,000,000	-1,524,000,000	-355,000,000	-393,000,000			-810,000,000			-467,000,000	0	-613,000,000	-887,000,000				0			-2,503,500,000	-700,000
proceeds from sale of subsidiaries														679,000,000	15,000,000
cash paid for prescriptions dispensed and health services rendered												-51,095,000,000	-50,223,000,000
cash paid for inventory and prescriptions dispensed by retail network pharmacies														-50,981,000,000	-47,898,000,000	-46,522,000,000	-44,365,000,000	-43,654,000,000	-42,813,000,000	-40,145,000,000	-39,171,000,000	-42,046,000,000	-40,209,000,000	-39,412,000,000	-36,969,000,000	-39,697,000,000	-39,391,000,000	-34,922,000,000	-35,645,000,000	-37,820,000,000	-36,305,000,000	-36,195,000,000	-38,491,000,000	-37,040,000,000	-37,570,000,000	-36,178,000,000	-35,520,000,000	-35,276,000,000	-35,575,000,000	-31,401,000,000	-29,853,000,000	-28,276,000,000	-26,799,000,000	-26,302,000,000	-23,966,000,000	-23,169,000,000	-22,387,000,000	-22,270,000,000			-22,515,000,000			-17,445,000,000	-17,567,000,000	-17,805,000,000	-17,581,000,000
proceeds from sale-leaseback transactions																																	0							0	9,000,000	25,000,000	323,000,000	0	5,000,000							0	0	11,000,000				245,100,000	497,300,000	5,800,000	127,300,000	64,300,000	5,300,000	563,800,000	13,800,000	13,800,000	9,900,000
derivative settlements																						0				0				0	0	446,000,000																							0
net decrease in cash, cash equivalents and restricted cash																852,000,000	-1,080,000,000
net borrowings of short-term debt																					252,000,000				255,000,000
proceeds from sale of subsidiary																														0	0	725,000,000																	0	0	7,000,000
net repayments of short-term debt
proceeds from sale of subsidiaries and other assets
effect of exchange rate changes on cash, cash equivalents and restricted cash
proceeds from sale of subsidiary and other assets
net borrowings (repayments) of short-term debt																													2,285,000,000
interest received																														212,000,000	144,000,000	50,000,000	6,000,000	5,000,000	4,000,000	6,000,000	5,000,000	4,000,000	5,000,000	6,000,000	6,000,000	3,000,000	5,000,000	3,000,000	3,000,000	3,000,000	1,000,000	1,000,000	1,000,000	0	1,000,000	1,000,000	1,000,000	1,000,000	1,000,000	1,000,000	1,000,000	1,100,000	1,200,000	1,900,000	4,300,000	3,800,000	6,300,000		8,000,000	7,900,000	7,700,000
proceeds from sale of property and equipment and other assets																														4,000,000	5,000,000	2,000,000	13,000,000	7,000,000	8,000,000	5,000,000	11,000,000	9,000,000	2,000,000	14,000,000	6,000,000	8,000,000
acquisitions (net of cash acquired) and other investments																														-83,000,000	-205,000,000	-368,000,000	-785,000,000	-187,000,000	-205,000,000	-110,000,000	-165,000,000	-117,000,000	-51,000,000	-9,391,000,000	-51,000,000	-61,000,000	-144,000,000	-54,000,000	-2,194,000,000	-54,000,000	-46,000,000	-254,000,000			-74,000,000			-11,000,000							-13,900,000			-22,100,000	-19,900,000
purchase of available-for-sale investments																														-21,000,000	-18,000,000	-18,000,000					-1,000,000	-3,000,000	-36,000,000	-60,000,000	-11,000,000	-113,000,000	0	-118,000,000	-43,000,000
maturities of available-for-sale investments																														6,000,000	27,000,000	10,000,000	40,000,000	5,000,000
decrease in short-term debt																														0	0	-1,276,000,000				-106,000,000						-185,000,000					-300,000,000	-390,000,000			-750,000,000
reconciliation of net income to net cash from operating activities:
net income																														1,390,000,000	-2,563,000,000	998,000,000	3,287,000,000	1,285,000,000	1,098,000,000	953,000,000	1,541,000,000	924,000,000	1,147,000,000	1,247,000,000	1,272,000,000	1,221,000,000	948,000,000	1,246,000,000	1,129,000,000	1,254,000,000	1,121,000,000	956,000,000	1,006,000,000	965,000,000	775,000,000	867,000,000	815,000,000	712,000,000	808,000,000	821,000,000	770,000,000
adjustments required to reconcile net income to net cash from operating activities:
depreciation and amortization																														620,000,000	647,000,000	644,000,000	622,000,000	615,000,000	623,000,000	619,000,000	611,000,000	619,000,000	617,000,000	532,000,000	488,000,000	490,000,000	477,000,000	488,000,000	477,000,000	461,000,000	449,000,000	502,000,000	443,000,000	431,000,000	423,000,000	407,000,000	391,000,000	374,000,000	370,000,000	368,000,000	358,000,000	300,300,000	382,300,000	353,900,000	310,900,000	310,000,000	299,300,000	276,100,000	301,700,000	308,000,000	208,800,000
goodwill impairments																														0
losses on settlements of defined benefit pension plans																																	0
stock-based compensation																														62,000,000	55,000,000	55,000,000	61,000,000	65,000,000	53,000,000	55,000,000	59,000,000	50,000,000	57,000,000	87,000,000	44,000,000	44,000,000	44,000,000	42,000,000	35,000,000	35,000,000	32,000,000	34,000,000	33,000,000	28,000,000	36,000,000	35,000,000	29,000,000	36,000,000	37,000,000	38,000,000	37,000,000
deferred income taxes and other noncash items																														44,000,000	190,000,000	62,000,000		250,000,000	7,000,000	14,000,000	44,000,000	58,000,000	17,000,000	-190,000,000	37,000,000	-31,000,000	-108,000,000	28,000,000	16,000,000	47,000,000	16,000,000	66,000,000	4,000,000	62,000,000	21,000,000
change in operating assets and liabilities, net of effects from acquisitions:
accounts receivable																														-666,000,000	-202,000,000	-857,000,000	-661,000,000	-166,000,000	-162,000,000	48,000,000	-435,000,000	-148,000,000	-1,131,000,000	-1,319,000,000	-730,000,000	-481,000,000	-1,288,000,000	-445,000,000	-139,000,000	-943,000,000	-462,000,000	-113,000,000			-70,000,000			-423,000,000	-10,000,000	48,000,000	308,000,000	-185,200,000	-161,700,000	26,100,000	-341,600,000	165,700,000	-43,800,000	-57,500,000	-229,300,000	367,600,000	198,900,000
inventories																														103,000,000	-95,000,000	464,000,000	-1,134,000,000	128,000,000	36,000,000	456,000,000	-170,000,000	-256,000,000	89,000,000	-428,000,000	-152,000,000	-313,000,000	-214,000,000	-171,000,000	-64,000,000	-243,000,000	11,000,000	193,000,000			-776,000,000	-268,000,000	70,000,000	514,000,000	-196,000,000	-114,000,000	68,000,000	-577,000,000	-347,800,000	92,800,000	-344,000,000	-11,900,000	18,800,000	-114,600,000	-142,500,000	-321,000,000	130,100,000
other current assets																														161,000,000	-101,000,000	56,000,000	-129,000,000	-181,000,000	43,000,000	-74,000,000	172,000,000	-276,000,000	106,000,000	460,000,000	-138,000,000	269,000,000	-86,000,000	-144,000,000	70,000,000	11,000,000	-73,000,000	238,000,000	171,000,000	-32,000,000	286,000,000			-30,000,000	-10,000,000	8,000,000	-39,000,000	19,200,000	33,600,000	-64,700,000	-12,600,000	-34,400,000	4,100,000	-37,900,000	-1,400,000	900,000	-20,800,000
other assets																														10,000,000	-16,000,000	-113,000,000	18,000,000	23,000,000			-33,000,000	-1,000,000	-52,000,000	35,000,000	4,000,000	-52,000,000	4,000,000	16,000,000	-39,000,000	13,000,000	-3,000,000	-135,000,000			-189,000,000			-52,000,000	15,000,000			-4,400,000	21,500,000	-24,000,000	-5,200,000	7,200,000	3,100,000	-1,300,000	-12,000,000	-23,200,000	10,100,000
accounts payable and claims and discounts payable																														794,000,000	1,223,000,000	-178,000,000	1,380,000,000	150,000,000	719,000,000	-539,000,000	406,000,000	366,000,000	798,000,000	655,000,000	627,000,000	756,000,000	701,000,000	182,000,000	339,000,000	599,000,000	328,000,000	-230,000,000				-6,000,000	187,000,000	535,000,000	174,000,000	-171,000,000	-115,000,000	292,300,000	62,700,000	-114,800,000	179,900,000	-353,700,000	-190,900,000				-188,300,000
accrued expenses																														-1,484,000,000	-88,000,000	1,231,000,000	-2,041,000,000	325,000,000	-503,000,000	1,848,000,000	1,585,000,000	-249,000,000	741,000,000	764,000,000	-394,000,000	153,000,000	643,000,000	-329,000,000	362,000,000	444,000,000	-517,000,000	105,000,000	-770,000,000	-155,000,000	1,250,000,000	926,000,000	-102,000,000	156,000,000	50,000,000	-282,000,000	-335,000,000	-50,000,000	-473,400,000	-270,400,000	213,100,000	-226,600,000	-108,000,000	219,100,000	-52,200,000	-287,300,000	-47,800,000
other long-term liabilities																														63,000,000			-33,000,000	-70,000,000	-13,000,000	154,000,000	44,000,000	-18,000,000	23,000,000	-23,000,000	-21,000,000	-72,000,000	3,000,000	-16,000,000	-14,000,000	25,000,000	0	24,000,000			-14,000,000			-26,000,000	-9,000,000	-38,000,000	6,000,000	44,100,000	68,300,000	-21,800,000	-14,800,000	4,500,000	-1,900,000	-26,400,000	-9,800,000	14,000,000	5,700,000
increase in short-term debt																																	1,166,000,000	-990,000,000			-405,000,000			-1,488,000,000															-468,000,000	1,337,000,000	200,000,000
purchase of noncontrolling interest in subsidiary																																					0	0	-39,000,000
payment of contingent consideration
effect of exchange rate changes on cash and cash equivalents																																					0	1,000,000	1,000,000	-7,000,000	-4,000,000	3,000,000	-1,000,000			7,000,000
net increase in cash and cash equivalents																																													-1,323,000,000	331,000,000	-377,000,000	176,000,000	-590,000,000	-388,000,000	798,000,000	-521,000,000	66,000,000	735,000,000							666,600,000	-202,500,000	-238,400,000	329,500,000	-85,200,000	101,600,000	180,000,000
cash and cash equivalents at the beginning of the period																																	0	0	0	3,371,000,000
cash and cash equivalents at the end of the period																																	-789,000,000	391,000,000	-123,000,000	2,217,000,000
loss on early extinguishment of debt																																					101,000,000
deferred income taxes
other noncash items
net decrease in cash and cash equivalents																																		391,000,000	-123,000,000	-1,154,000,000		-652,000,000	-680,000,000		-274,000,000	-963,000,000															-39,000,000		227,900,000	-355,000,000
goodwill impairment																																		0
maturity of available-for-sale investments																																				8,000,000
sales/maturities of available-for-sale investments																																					9,000,000	17,000,000	50,000,000	75,000,000	24,000,000	16,000,000	16,000,000	48,000,000	55,000,000
excess tax benefits from stock-based compensation																																					9,000,000	36,000,000	27,000,000	35,000,000	38,000,000	59,000,000	24,000,000	28,000,000	37,000,000	14,000,000	21,000,000	13,000,000	13,000,000						0	2,000,000	11,000,000
cash and cash equivalents at beginning of period																																					0	0	2,459,000,000	0	0	2,481,000,000	0	0	4,089,000,000	0	0	1,375,000,000	0	0	1,413,000,000	0	0	1,427,000,000	0	0	1,086,000,000	0	0	1,352,400,000	0	0	1,056,600,000		0	0	530,700,000
cash and cash equivalents at end of period																																					1,062,000,000	-652,000,000	1,779,000,000	1,646,000,000	-274,000,000	1,518,000,000	-480,000,000	-1,154,000,000	2,766,000,000	331,000,000	-377,000,000	1,551,000,000	-590,000,000	-388,000,000	2,211,000,000	-521,000,000	66,000,000	2,162,000,000	-128,000,000	60,000,000	1,047,000,000	-94,700,000	227,900,000	997,400,000	666,600,000	-202,500,000	818,200,000		-85,200,000	101,600,000	710,700,000
adjustments to reconcile net income to net cash from operating activities:
proceeds from sale of property and equipment																																											1,000,000	2,000,000	5,000,000	2,000,000	6,000,000	5,000,000						12,000,000
reconciliation of net income to net cash provided by operating activities:
adjustments to reconcile net income to net cash provided by operating activities:
accounts payable																																																		-389,000,000	1,044,000,000
purchase of short-term investments
maturity of short-term investments																																																				1,000,000			0	0	1,000,000
deferred income taxes and other non-cash items																																																				5,000,000	59,000,000	70,000,000	63,000,000	-22,000,000	2,000,000	9,000,000	27,100,000	33,800,000	32,200,000	-6,500,000	-1,600,000	78,400,000			-20,200,000
change in operating assets and liabilities, net of effects of acquisitions:
cash receipts from revenues																																																					24,979,000,000	22,971,000,000	22,779,000,000	22,827,000,000	22,918,000,000	17,706,900,000	17,827,000,000	17,282,700,000	14,510,500,000	14,482,000,000	16,321,600,000	17,716,400,000	15,655,700,000	15,753,200,000	12,861,000,000
additions to property and equipment																																																							-513,000,000	-465,000,000	-401,000,000	-661,200,000	-624,900,000	-466,400,000	-527,900,000	-555,000,000	-400,300,000	-572,600,000	-454,700,000	-466,100,000	-311,900,000
proceeds from sale or disposal of assets																																																							14,000,000	-2,000,000	12,000,000	500,000	4,800,000	1,700,000	4,100,000	4,700,000	4,800,000	900,000	18,600,000	72,900,000	13,200,000
acquisitions (net of cash acquired) and investments																																																							-133,000,000	-16,000,000	-9,000,000	-17,000,000	-39,400,000	13,100,000			15,900,000				-1,975,000,000
issuance of long-term debt
decrease in long-term debt																																																									-1,000,000
cash paid for inventory																																																										-12,700,900,000	-12,841,900,000	-12,187,500,000	-10,296,000,000	-9,968,300,000	-12,459,800,000	-10,759,800,000	-13,175,900,000	-12,350,200,000	-9,486,700,000
sale of short-term investments																																																													0
net reduction in short-term debt
sale of short-term investment																																																															27,500,000
net reductions in short-term debt																																																											-90,000,000	-1,626,100,000
excess tax benefits from stock based compensation																																																											3,600,000	1,200,000	3,100,000	25,100,000	27,100,000	49,000,000	18,700,000	22,400,000	7,700,000
additions to long-term debt																																																											900,000	999,100,000				0	0	5,500,000,000	500,000,000
reductions to long-term debt
reconciliation of net earnings to net cash from operating activities:
net earnings																																																											886,500,000	738,400,000	736,000,000	774,800,000	748,500,000	815,000,000	689,500,000	723,600,000	408,900,000
adjustments required to reconcile net earnings to net cash from operating activities:
stock based compensation																																																											52,800,000	22,000,000	32,300,000	22,200,000	13,200,000	18,700,000	12,300,000	24,700,000	22,300,000
change in operating assets and liabilities, providing/(requiring) cash, net of effects from acquisitions:
reductions in long-term debt																																																													-700,000	-700,000	-600,000	-300,700,000	-500,000	-502,300,000	-18,300,000
reductions in short-term debt																																																													2,000,000
(reductions in) additions to short-term debt																																																															-743,100,000
interest and dividends received
cash outflow from hedging activities
additions to/ (reductions in) short-term debt
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
change in operating assets and liabilities providing/(requiring) cash, net of effects from acquisitions:
(reductions in)/additions to short-term debt																																																																	-235,400,000
adjustments required to reconcile net earnings to net cash provided by operating activities:
accounts and claims and discounts payable
purchase of short-term investment
additions to short-term debt																																																																			1,230,100,000

CVS Health Corporation(NYSE:CVS)

CVS Health Corporation
(NYSE:CVS)